Outcome measures used in Neuro-physiotherapy-Global measures of disability this the main topic of seminar, it should include from basic what is outcome measures, types of relibilty , validity , feasibility, psyomotor property , how to know whether the scale is more reliable, validity, with standard defination and explaination with thier refrence below in Vancouver formate , then in main topic it should include standard defination for global disablity , domain , then the list of scales with referenence in Vancouver formate , all the statment in the ppt must have references

Reading File
Reading File
Reading File
Searching the Web

outcome measures global disability neurological rehabilitation Modified Rankin Scale Barthel Index Functional Independence Measure references

Finding Sources
Finding Sources
Searching PubMed

neurological rehabilitation AND outcome measures

Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed

outcome measures AND neurological rehabilitation

Searching PubMed

modified Rankin scale AND reliability validity

Searching PubMed

Barthel Index AND reliability validity

Searching PubMed

psychometric properties AND outcome measures rehabilitation

Browsing Directory

~/

Running Command

mkdir -p "/tmp/workspace/neuro-global-disability-ppt/src" "/tmp/workspace/neuro-global-disability-ppt/output" && python - <<'PY' from pathlib import Path p=Path('/tmp/workspace/neuro-global-disability-ppt/src/create_presentation.py') p.write_text(r'''from pptx import Presentation from pptx.util import Inches, Pt from pptx.dml.color import RGBColor from pptx.enum.text import PP_ALIGN, MSO_ANCHOR from pptx.enum.shapes import MSO_SHAPE, MSO_CONNECTOR from pptx.enum.dml import MSO_THEME_COLOR from pptx.enum.text import MSO_AUTO_SIZE from pptx.enum.shapes import MSO_AUTO_SHAPE_TYPE from pptx.enum.text import MSO_ANCHOR OUT = "/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability.pptx" prs=Presentation(); prs.slide_width=Inches(13.333); prs.slide_height=Inches(7.5) blank=prs.slide_layouts[6] # palette NAVY=RGBColor(18,45,75); TEAL=RGBColor(0,126,135); SKY=RGBColor(221,243,246); INK=RGBColor(31,43,54); MUTED=RGBColor(91,105,118); WHITE=RGBColor(255,255,255); GOLD=RGBColor(245,180,60); PALE=RGBColor(244,248,250); LINE=RGBColor(202,218,224); RED=RGBColor(180,61,65); GREEN=RGBColor(35,126,91) refs=[ "World Health Organization. International classification of functioning, disability and health: ICF. Geneva: WHO; 2001.", "Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties. J Clin Epidemiol. 2010;63(7):737-45.", "Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42.", "de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.", "Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155-63.", "Mokkink LB, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, de Vet HCW, Terwee CB. COSMIN study design checklist for patient-reported outcome measurement instruments. Amsterdam: VU Medical Center; 2019.", "Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2(5):200-15.", "van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-7.", "Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393-5.", "Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-5.", "Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud. 1988;10(2):61-3.", "Duffy L, Gajree S, Langhorne P, Stott DJ, Quinn TJ. Reliability (inter-rater agreement) of the Barthel Index for assessment of stroke survivors: systematic review and meta-analysis. Stroke. 2013;44(2):462-8.", "Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.", "Hamilton BB, Laughlin JA, Fiedler RC, Granger CV. Interrater reliability of the 7-level Functional Independence Measure (FIM). Scand J Rehabil Med. 1994;26(3):115-9.", "Rappaport M, Hall KM, Hopkins K, Belleza T, Cope DN. Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil. 1982;63(3):118-23.", "Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480-4.", "Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15(8):573-85.", "Üstün TB, Kostanjsek N, Chatterji S, Rehm J, editors. Measuring health and disability: manual for WHO Disability Assessment Schedule WHODAS 2.0. Geneva: WHO; 2010.", "Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444-52.", "Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-70.", "Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1-2):13-21.", "Catz A, Itzkovich M, Agranov E, Ring H, Tamir A. SCIM-spinal cord independence measure: a new disability scale for patients with spinal cord lesions. Spinal Cord. 1997;35(12):850-6.", "Playford ED. Outcome measurement in neurological disease. Curr Opin Neurol. 2008;21(4):461-6.", "Kwon S, Hartzema AG, Duncan PW, Min-Lai S. Disability measures in stroke: relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale. Stroke. 2004;35(4):918-23.", "Cieza A, Fayed N, Bickenbach J, Prodinger B. Refinements of the ICF linking rules to strengthen their potential for establishing comparability of health information. Disabil Rehabil. 2019;41(5):574-83.", ] def bg(slide, title, subtitle=None, section=None): slide.background.fill.solid(); slide.background.fill.fore_color.rgb=WHITE # top band shp=slide.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,0,prs.slide_width,Inches(.36)); shp.fill.solid(); shp.fill.fore_color.rgb=NAVY; shp.line.fill.background() if section: text(slide, section.upper(), .55,.52, 4,.22, 9, TEAL, bold=True) text(slide,title,.55,.75,12.2,.58,27,NAVY,bold=True) if subtitle: text(slide,subtitle,.56,1.34,12,.35,12,MUTED) # footer slide.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,Inches(7.13),prs.slide_width,Inches(.37)).fill.solid() slide.shapes[-1].fill.fore_color.rgb=NAVY; slide.shapes[-1].line.fill.background() def text(slide,s,x,y,w,h,size=18,color=INK,bold=False,align=PP_ALIGN.LEFT, valign=MSO_ANCHOR.TOP, italic=False): tb=slide.shapes.add_textbox(Inches(x), Inches(y), Inches(w), Inches(h)) tf=tb.text_frame; tf.clear(); tf.word_wrap=True; tf.margin_left=0;tf.margin_right=0;tf.margin_top=0;tf.margin_bottom=0; tf.vertical_anchor=valign p=tf.paragraphs[0]; p.alignment=align r=p.add_run();r.text=s;r.font.name='Aptos';r.font.size=Pt(size);r.font.bold=bold;r.font.italic=italic;r.font.color.rgb=color return tb def sources(slide, nums): text(slide,'Sources: '+', '.join(f'[{n}]' for n in nums),.56,7.205,11.8,.15,8,WHITE) def box(slide,x,y,w,h,heading,body,accent=TEAL,head_size=15,body_size=12): shp=slide.shapes.add_shape(MSO_SHAPE.ROUNDED_RECTANGLE, Inches(x), Inches(y), Inches(w), Inches(h));shp.fill.solid();shp.fill.fore_color.rgb=PALE;shp.line.color.rgb=LINE strip=slide.shapes.add_shape(MSO_SHAPE.RECTANGLE, Inches(x), Inches(y), Inches(.09), Inches(h));strip.fill.solid();strip.fill.fore_color.rgb=accent;strip.line.fill.background() text(slide,heading,x+.22,y+.18,w-.36,.3,head_size,NAVY,bold=True) text(slide,body,x+.22,y+.56,w-.38,h-.68,body_size,INK) def bullet_slide(title, subtitle, bullets, refs_, section='FOUNDATIONS'): s=prs.slides.add_slide(blank); bg(s,title,subtitle,section) y=1.92 for b in bullets: circ=s.shapes.add_shape(MSO_SHAPE.OVAL, Inches(.66), Inches(y+.05), Inches(.18), Inches(.18)); circ.fill.solid();circ.fill.fore_color.rgb=TEAL;circ.line.fill.background() text(s,b,.98,y,11.65,.52,16,INK) y+=.78 sources(s,refs_); return s # title s=prs.slides.add_slide(blank);s.background.fill.solid();s.background.fill.fore_color.rgb=NAVY s.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,0,Inches(.22),prs.slide_height).fill.solid();s.shapes[-1].fill.fore_color.rgb=GOLD;s.shapes[-1].line.fill.background() text(s,'Outcome Measures Used in\nNeuro-Physiotherapy',.78,1.20,9.7,1.4,34,WHITE,bold=True) text(s,'Global measures of disability',.8,2.82,7.4,.5,22,RGBColor(184,226,230)) text(s,'Seminar presentation',.82,3.5,5,.3,14,WHITE) text(s,'Concepts • psychometric properties • selecting and interpreting global disability scales',.82,5.93,10.8,.35,13,RGBColor(215,230,236)) sources(s,[1,2,23]) # objectives bullet_slide('Learning objectives','By the end, learners should be able to:',[ 'Define outcome measure, disability, global disability measure, domain and psychometric property.', 'Distinguish reliability, validity, responsiveness and feasibility, and interpret common statistics.', 'Select an appropriate global disability scale for a neurological population and intended decision.', 'Compare commonly used measures and document results without overstating what a scale measures.' ],[1,2,3,4], 'SEMINAR MAP') # definition outcome s=prs.slides.add_slide(blank);bg(s,'What is an outcome measure?','A structured method to quantify a health-related construct at one or more time points.','FOUNDATIONS') box(s,.65,1.95,3.8,3.35,'Outcome','The observed result of care or disease over time, such as change in functioning, participation or health status.',TEAL,17,15) box(s,4.78,1.95,3.8,3.35,'Outcome measure','An instrument, test, rating scale or questionnaire that operationalises the construct using standard rules for administration, scoring and interpretation.',GOLD,17,15) box(s,8.91,1.95,3.75,3.35,'In neuro-physiotherapy','It supports baseline description, goal setting, treatment monitoring, communication, audit and research. The measure must fit the intended construct.',GREEN,17,15) text(s,'Key principle: a score is meaningful only when the construct, target population, setting and purpose match.',.8,5.85,11.7,.45,17,NAVY,bold=True,align=PP_ALIGN.CENTER) sources(s,[2,4,23]) # ICF s=prs.slides.add_slide(blank);bg(s,'Where does “disability” sit?','The ICF describes functioning as an interaction between health condition and contextual factors.','FOUNDATIONS') items=[('Body functions & structures','e.g., strength, tone, sensation','IMPAIRMENT'),('Activities','e.g., transfer, walking, dressing','ACTIVITY LIMITATION'),('Participation','e.g., work, family and community roles','PARTICIPATION RESTRICTION')] for i,(h,b,tag) in enumerate(items): x=.65+i*4.15 box(s,x,2.05,3.65,2.1,h,b,[TEAL,GOLD,GREEN][i],16,14) text(s,tag,x+.18,4.4,3.3,.25,10,[TEAL,GOLD,GREEN][i],bold=True,align=PP_ALIGN.CENTER) text(s,'Personal and environmental factors can facilitate or hinder functioning across every domain.',.85,5.25,11.5,.45,17,NAVY,bold=True,align=PP_ALIGN.CENTER) sources(s,[1,25]) # global disability definition domain s=prs.slides.add_slide(blank);bg(s,'Global measures of disability','They summarise overall dependence, functional consequence or disability burden rather than one isolated impairment.','GLOBAL DISABILITY') box(s,.7,1.95,5.8,2.35,'Working definition','A global disability measure provides a broad, usually ordinal summary of a person’s functional status or dependence across multiple activities, or an overall clinician judgement of disability.',TEAL,18,15) box(s,6.82,1.95,5.8,2.35,'Domain','A domain is a distinct aspect of the construct measured by an instrument. For example: self-care, mobility, communication, cognition, social function or participation.',GOLD,18,15) text(s,'Global does not mean complete: the score may conceal which specific task or domain is limiting function.',.85,5.0,11.5,.5,18,RED,bold=True,align=PP_ALIGN.CENTER) sources(s,[1,2,23,24]) # taxonomy s=prs.slides.add_slide(blank);bg(s,'Types of outcome measures','Classify first by the construct and who reports it.','FOUNDATIONS') box(s,.65,1.85,3.85,1.7,'Impairment measures','Body function or structure: e.g., range, strength, spasticity. Not global disability.',TEAL,16,13) box(s,4.75,1.85,3.85,1.7,'Activity measures','Ability to perform a task: e.g., gait test, transfer, ADL subscale.',GOLD,16,13) box(s,8.85,1.85,3.85,1.7,'Global disability measures','Overall level of dependence or functional consequence: e.g., mRS, FIM, DRS.',GREEN,16,13) box(s,.65,4.05,5.9,1.45,'Clinician/performance rated','Observed rating or timed test. Strength: standardised observation. Risk: rater variation.',TEAL,16,13) box(s,6.8,4.05,5.9,1.45,'Patient-reported outcome measure','Patient’s perception of function, symptoms or participation. Strength: patient perspective. Risk: recall/response effects.',GOLD,16,13) sources(s,[1,2,23]) # psychometric s=prs.slides.add_slide(blank);bg(s,'Psychometric properties','Psychometrics asks whether the scores can be trusted for their intended use.','PSYCHOMETRICS') props=[('Reliability','Consistency of scores when the true state is unchanged.'),('Validity','Evidence supporting the intended interpretation of scores.'),('Responsiveness','Ability to detect meaningful change over time.'),('Interpretability','Meaning assigned to scores or score changes.'),('Feasibility','Practical fit: time, cost, burden, training, access.')] for i,(h,b) in enumerate(props): x=.65+(i%3)*4.15;y=1.85+(i//3)*2.15 box(s,x,y,3.75,1.65,h,b,[TEAL,GOLD,GREEN,RED,NAVY][i],15,12) sources(s,[2,3,4,6]) # reliability types s=prs.slides.add_slide(blank);bg(s,'Reliability: standard definition and types','Reliability is the proportion of observed-score variance attributable to true differences, rather than measurement error.','RELIABILITY') box(s,.62,1.85,3.9,1.65,'Test-retest reliability','Same rater, same person, stable condition, two time points. Evaluates temporal stability.',TEAL,16,13) box(s,4.72,1.85,3.9,1.65,'Inter-rater reliability','Different raters score the same person or standardised case. Essential for observer-rated scales.',GOLD,16,13) box(s,8.82,1.85,3.9,1.65,'Intra-rater reliability','The same rater repeats the rating under stable conditions. Tests rater consistency.',GREEN,16,13) box(s,2.65,4.25,3.9,1.65,'Internal consistency','How closely items in a multi-item scale relate to the same underlying construct. Not relevant to a single-item scale.',RED,16,13) box(s,6.76,4.25,3.9,1.65,'Agreement / measurement error','Absolute closeness of repeated scores. Report SEM and MDC alongside relative reliability.',NAVY,16,13) sources(s,[2,3,4]) # reliability statistics s=prs.slides.add_slide(blank);bg(s,'How do you judge whether a scale is more reliable?','Compare like with like: same population, administration method, interval and statistic.','RELIABILITY') box(s,.65,1.85,5.9,1.18,'For continuous scores','Use ICC with 95% CI. Common rule of thumb: ICC ≥0.70 may support group comparison; ≥0.90 is preferred for individual-level decisions.',TEAL,16,13) box(s,6.78,1.85,5.9,1.18,'For ordinal / categorical scores','Use weighted kappa (or appropriate agreement statistic) with 95% CI. Do not use correlation alone as evidence of agreement.',GOLD,16,13) box(s,.65,3.45,5.9,1.18,'For multi-item scales','Cronbach α of 0.70-0.95 is commonly considered acceptable evidence of internal consistency, provided the scale is unidimensional.',GREEN,16,13) box(s,6.78,3.45,5.9,1.18,'Inspect error and precision','Smaller SEM and MDC indicate less random error. Reliability can appear high in a heterogeneous sample, so report the sample and confidence interval.',RED,16,13) text(s,'Better reliability means reproducible scores with sufficiently small error for the decision you need, not simply the highest single coefficient.',.9,5.65,11.5,.45,16,NAVY,bold=True,align=PP_ALIGN.CENTER) sources(s,[3,4,5,6]) # validity s=prs.slides.add_slide(blank);bg(s,'Validity: standard definition and types','Validity concerns the degree to which evidence and theory support the intended interpretation of scores.','VALIDITY') box(s,.65,1.85,3.85,2.4,'Content validity','Items adequately represent the construct for the target population and purpose. Requires patients and experts; foundational property.',TEAL,16,13) box(s,4.75,1.85,3.85,2.4,'Construct validity','Scores behave as predicted: known-groups differences, hypothesised correlations and structural validity support the construct.',GOLD,16,13) box(s,8.85,1.85,3.85,2.4,'Criterion validity','Scores agree with a credible gold standard. Often difficult for disability constructs because no true gold standard exists.',GREEN,16,13) text(s,'Face validity is whether a measure appears relevant. It can aid acceptability but is not sufficient evidence of validity.',.85,5.15,11.6,.45,16,RED,bold=True,align=PP_ALIGN.CENTER) sources(s,[2,3,4,6]) # validity / scale selection s=prs.slides.add_slide(blank);bg(s,'How do you judge whether a scale is more valid?','Ask “valid for which interpretation, population and decision?” rather than “is it valid?”','VALIDITY') steps=[('1. Define construct','Overall disability, ADL dependence, participation, or a disease-specific disability?'),('2. Check content','Were relevant patients and clinicians involved? Are important domains missing?'),('3. Check structure & hypotheses','Does factor/Rasch evidence fit? Do correlations and known-group findings match prespecified hypotheses?'),('4. Check population & setting','Validation sample should resemble your diagnosis, severity, language, culture and care setting.'),('5. Check interpretation','Are floor/ceiling effects, MDC/MCID, score direction and recall period known?')] for i,(h,b) in enumerate(steps): y=1.7+i*.9 text(s,f'{i+1}',.72,y+.05,.32,.3,16,WHITE,bold=True,align=PP_ALIGN.CENTER) circ=s.shapes.add_shape(MSO_SHAPE.OVAL,Inches(.66),Inches(y),Inches(.42),Inches(.42));circ.fill.solid();circ.fill.fore_color.rgb=[TEAL,GOLD,GREEN,RED,NAVY][i];circ.line.fill.background() text(s,h,1.25,y,3.0,.28,15,NAVY,bold=True); text(s,b,4.05,y,8.4,.35,13,INK) sources(s,[2,3,4,6]) # feasibility s=prs.slides.add_slide(blank);bg(s,'Feasibility and clinical utility','A highly psychometrically sound scale is not useful if it cannot be administered consistently in the real setting.','FEASIBILITY') items=[('Time','Completion, scoring and documentation time'),('Burden','Fatigue, cognition, language, pain and caregiver load'),('Training','Rater manual, certification and standard interview requirements'),('Cost / access','Licence, devices, translation and availability'),('Interpretability','Clear score direction, meaningful categories and usable benchmarks'),('Data quality','Missing items, floor/ceiling effects and need for proxy response')] for i,(h,b) in enumerate(items): box(s,.7+(i%3)*4.15,1.75+(i//3)*2.1,3.75,1.55,h,b,[TEAL,GOLD,GREEN,RED,NAVY,TEAL][i],15,12) sources(s,[2,3,4,23]) # mRS s=prs.slides.add_slide(blank);bg(s,'Modified Rankin Scale (mRS)','Brief global disability/handicap scale most commonly used after stroke.','CORE GLOBAL SCALES') text(s,'0 No symptoms 1 No significant disability 2 Slight disability',.75,1.85,11.9,.34,15,NAVY,bold=True,align=PP_ALIGN.CENTER) text(s,'3 Moderate disability 4 Moderately severe disability 5 Severe disability 6 Death',.75,2.27,11.9,.34,15,NAVY,bold=True,align=PP_ALIGN.CENTER) box(s,.75,3.05,3.75,2.1,'What it captures','A single ordinal global judgement of disability and dependence. It is not a detailed ADL profile.',TEAL,16,13) box(s,4.8,3.05,3.75,2.1,'Strengths','Very brief; clinically familiar; supports comparison of global post-stroke outcome.',GOLD,16,13) box(s,8.85,3.05,3.75,2.1,'Limitations','Rater interpretation can vary. Structured interview and rater training improve standardisation. Ordinal categories are not equal intervals.',RED,16,13) sources(s,[7,8,9,24]) # BI FIM s=prs.slides.add_slide(blank);bg(s,'Barthel Index (BI) and Functional Independence Measure (FIM)','Both describe assistance required for daily function, but their content and scoring differ.','CORE GLOBAL SCALES') box(s,.65,1.82,5.9,3.75,'Barthel Index','• 10 ADL/mobility items\n• Common total score 0-100: greater score = greater independence\n• Measures basic activity and dependence\n• Useful for rapid ADL disability description\n• May show floor/ceiling effects depending on severity',TEAL,18,14) box(s,6.78,1.82,5.9,3.75,'FIM','• 18 items: 13 motor and 5 cognitive\n• Each item rated 1 (total assistance) to 7 (complete independence); total 18-126\n• Estimates burden of care across motor and cognitive tasks\n• Requires standardised administration/training',GOLD,18,14) text(s,'Do not exchange BI and FIM totals without a validated conversion for the intended population.',.8,5.95,11.7,.38,15,RED,bold=True,align=PP_ALIGN.CENTER) sources(s,[10,11,12,13,14,24]) # other scales s=prs.slides.add_slide(blank);bg(s,'Other global or broad disability measures in neurology','Choose a measure that matches the neurological condition and decision.','CORE GLOBAL SCALES') rows=[('Disability Rating Scale (DRS)','TBI, especially severe injury','Tracks disability from coma through community function; 8 items.'),('Glasgow Outcome Scale / Extended GOS','TBI','Global recovery categories; structured interview improves consistency.'),('WHODAS 2.0','Across health conditions','Patient/proxy-reported disability across six life domains; linked conceptually to ICF.'),('EDSS','Multiple sclerosis','Neurologic impairment and ambulation-focused disability; 0-10 ordinal scale.'),('MDS-UPDRS','Parkinson disease','Motor and non-motor impact; broad disease-specific outcome, not a generic disability scale.'),('ALSFRS-R / SCIM','ALS / spinal cord injury','Disease-specific functional disability measures for respective populations.')] for i,(h,p,b) in enumerate(rows): y=1.55+i*.82 text(s,h,.72,y,3.25,.25,14,NAVY,bold=True);text(s,p,4.02,y,2.0,.25,12,TEAL,bold=True);text(s,b,6.1,y,6.3,.31,12,INK) sources(s,[15,16,17,18,19,20,21,22]) # comparison table s=prs.slides.add_slide(blank);bg(s,'Comparison at a glance','This table supports initial selection, not automatic substitution of one measure for another.','CORE GLOBAL SCALES') headers=['Measure','Primary construct','Format / score','Best fit','Important caution'] xs=[.55,2.45,5.05,7.35,9.55]; ws=[1.75,2.35,2.05,2.0,3.1] for x,w,h in zip(xs,ws,headers): sh=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(x),Inches(1.65),Inches(w),Inches(.48));sh.fill.solid();sh.fill.fore_color.rgb=NAVY;sh.line.fill.background();text(s,h,x+.05,1.78,w-.1,.16,11,WHITE,bold=True,align=PP_ALIGN.CENTER) data=[('mRS','Global disability','1 item; 0-6','Stroke outcome','Broad categories'),('BI','Basic ADL dependence','10 items; often 0-100','Stroke / inpatient rehab','Less cognition/participation'),('FIM','Independence / burden of care','18 items; 18-126','Rehabilitation','Training / licensing context'),('DRS','TBI disability','8 items','TBI trajectory','Less granular ADL detail'),('WHODAS 2.0','Disability across life domains','12 or 36 items','Cross-condition','Self/proxy report'),('EDSS','MS disability','0-10 ordinal','Multiple sclerosis','Ambulation-weighted')] for r,row in enumerate(data): y=2.15+r*.66 for c,val in enumerate(row): sh=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(xs[c]),Inches(y),Inches(ws[c]),Inches(.62));sh.fill.solid();sh.fill.fore_color.rgb=PALE if r%2==0 else WHITE;sh.line.color.rgb=LINE;text(s,val,xs[c]+.05,y+.12,ws[c]-.1,.38,10,INK,bold=(c==0)) sources(s,[8,10,13,15,18,19,24]) # example clinical s=prs.slides.add_slide(blank);bg(s,'Worked selection example','A measure is selected from the clinical question, not because it is popular.','APPLICATION') box(s,.7,1.75,3.75,3.75,'Scenario','A 62-year-old person is 3 weeks after stroke. The physiotherapist needs to document rehabilitation goals and change in transfers, gait and self-care; the stroke team also needs a brief 90-day global endpoint.',TEAL,17,14) box(s,4.8,1.75,3.75,3.75,'Choice','• BI or FIM: describe assistance needed for ADL and rehabilitation planning.\n\n• mRS: communicate a brief overall stroke disability endpoint.\n\n• Add a mobility-specific measure if gait is the target.',GOLD,17,14) box(s,8.9,1.75,3.75,3.75,'Interpretation','Report the measure name, version, rater, date, total score and relevant item profile. Do not infer detailed mobility improvement from a global score alone.',GREEN,17,14) sources(s,[1,10,13,23,24]) # implementation s=prs.slides.add_slide(blank);bg(s,'A practical selection and implementation checklist','Use the same administration rules every time.','APPLICATION') checks=['Define the purpose: screening, goal setting, monitoring, audit, trial endpoint or discharge planning.','Specify the construct and ICF domain(s), then choose generic/global versus disease-specific measure.','Confirm evidence in the target diagnosis, severity, language/culture and setting.','Use the official version, scoring manual and required rater training.','Record baseline and repeat at a clinically appropriate, pre-specified interval.','Report score direction, missing items, total and domain/item results; interpret change against MDC/MCID if available.'] for i,c in enumerate(checks): y=1.62+i*.77 sh=s.shapes.add_shape(MSO_SHAPE.ROUNDED_RECTANGLE,Inches(.68),Inches(y),Inches(.47),Inches(.45));sh.fill.solid();sh.fill.fore_color.rgb=TEAL;sh.line.fill.background();text(s,str(i+1),.68,y+.11,.47,.14,11,WHITE,bold=True,align=PP_ALIGN.CENTER) text(s,c,1.35,y+.05,11.15,.35,14,INK) sources(s,[1,2,3,4,6,23]) # take homes bullet_slide('Key take-home messages','',[ 'Outcome measures are tools, not diagnoses. Start with the construct and intended decision.', 'Global disability scores give a broad summary, but need complementary domain-specific measures for treatment planning.', 'Reliability addresses consistency; validity supports the interpretation; responsiveness addresses meaningful change; feasibility determines uptake.', 'A more reliable or valid scale is one with evidence appropriate to your population, purpose, method and precision requirement.', 'Use official instructions, training and consistent timing, then report what the score can and cannot say.' ],[1,2,3,4,6,23], 'SUMMARY') # references 1 for start,end in [(0,13),(13,25)]: s=prs.slides.add_slide(blank); bg(s, f'References ({start+1}-{end})', 'Vancouver style', 'REFERENCES') y=1.62 for i,r in enumerate(refs[start:end],start+1): text(s,f'{i}. {r}',.68,y,12.0,.30,9.5,INK) y+=.375 sources(s, list(range(start+1,end+1))) # final qa s=prs.slides.add_slide(blank);bg(s,'Questions','Thank you','') text(s,'Discussion: Which global disability measure fits your current neuro-physiotherapy setting, and what decision will it inform?',1.1,2.55,11.1,1.0,24,NAVY,bold=True,align=PP_ALIGN.CENTER,valign=MSO_ANCHOR.MIDDLE) text(s,'Use the reference list and local protocol/manual before adopting a scale.',1.2,4.45,10.9,.4,16,TEAL,align=PP_ALIGN.CENTER) sources(s,[2,3,4,6]) prs.save(OUT) print(OUT) ''') PY python "/tmp/workspace/neuro-global-disability-ppt/src/create_presentation.py"

Running Command

python - <<'PY' from pptx import Presentation p='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability.pptx' prs=Presentation(p) print('slides', len(prs.slides)) for i,slide in enumerate(prs.slides,1): texts=[] for sh in slide.shapes: if getattr(sh,'has_text_frame',False) and sh.text.strip(): texts.append(sh.text.strip().replace('\n',' | ')) print(i, texts[0][:90] if texts else 'EMPTY') print('size', __import__('os').path.getsize(p)) PY

Reading Article

PMID: 19679846

Reading Article

PMID: 23299497

Reading Article

PMID: 18989107

Created a 22-slide seminar PowerPoint on Outcome Measures Used in Neuro-Physiotherapy: Global Measures of Disability.
It includes:
  • Basic definitions of outcome measures, disability, global disability, and domains
  • ICF framework and types of outcome measures
  • Psychometric properties
  • Reliability: types, ICC, kappa, internal consistency, SEM, MDC
  • Validity: content, construct, and criterion validity
  • Feasibility and clinical utility
  • How to decide whether a scale is more reliable or valid
  • Global disability scales: mRS, Barthel Index, FIM, DRS, GOS/GOSE, WHODAS 2.0, EDSS, MDS-UPDRS, ALSFRS-R, and SCIM
  • Scale comparison table and clinical selection example
  • Vancouver-style reference slides
  • Source citations on every content slide

Outcome Measures Neurophysiotherapy Global Disability

Presentation · PPTX

Yes it is good

Thank you.

But add more in detail that it can be explained and then give the list of all the scales maximum and make a tabel that includes the domain that covers their physometric property and from this scales explain only 5 scales that cover more than 2 domains and explain the psyomotor property in detial with standard defination and reference should be used strictly

Reading File
Reading File
Searching the Web

COSMIN definitions psychometric properties outcome measures reliability validity responsiveness official

Finding Sources
Searching PubMed

neurological rehabilitation AND outcome measures

Searching PubMed

psychometric properties AND neurological rehabilitation

Browsing Directory

~/

Reading File
Running Command

python - <<'PY' from pathlib import Path p=Path('/tmp/workspace/neuro-global-disability-ppt/src/append_detailed_content.py') p.write_text(r'''from pptx import Presentation from pptx.util import Inches, Pt from pptx.dml.color import RGBColor from pptx.enum.text import PP_ALIGN, MSO_ANCHOR from pptx.enum.shapes import MSO_SHAPE IN='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability.pptx' OUT='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability_DETAILED.pptx' prs=Presentation(IN); blank=prs.slide_layouts[6] NAVY=RGBColor(18,45,75); TEAL=RGBColor(0,126,135); INK=RGBColor(31,43,54); MUTED=RGBColor(91,105,118); WHITE=RGBColor(255,255,255); GOLD=RGBColor(245,180,60); PALE=RGBColor(244,248,250); LINE=RGBColor(202,218,224); RED=RGBColor(180,61,65); GREEN=RGBColor(35,126,91) def text(s,t,x,y,w,h,fs=14,c=INK,b=False,a=PP_ALIGN.LEFT): tb=s.shapes.add_textbox(Inches(x),Inches(y),Inches(w),Inches(h));tf=tb.text_frame;tf.clear();tf.word_wrap=True;tf.margin_left=0;tf.margin_right=0;tf.margin_top=0;tf.margin_bottom=0 p=tf.paragraphs[0];p.alignment=a;r=p.add_run();r.text=t;r.font.name='Aptos';r.font.size=Pt(fs);r.font.bold=b;r.font.color.rgb=c;return tb def bg(s,title,sub,section='DETAILED CONTENT'): s.background.fill.solid();s.background.fill.fore_color.rgb=WHITE sh=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,0,prs.slide_width,Inches(.36));sh.fill.solid();sh.fill.fore_color.rgb=NAVY;sh.line.fill.background() text(s,section,.55,.52,5,.2,9,TEAL,True);text(s,title,.55,.75,12.2,.55,25,NAVY,True);text(s,sub,.56,1.34,12,.25,11,MUTED) sh=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,Inches(7.13),prs.slide_width,Inches(.37));sh.fill.solid();sh.fill.fore_color.rgb=NAVY;sh.line.fill.background() def src(s,n):text(s,'Sources: '+', '.join('['+str(i)+']' for i in n),.56,7.205,12,.12,8,WHITE) def box(s,x,y,w,h,hd,bd,ac=TEAL): sh=s.shapes.add_shape(MSO_SHAPE.ROUNDED_RECTANGLE,Inches(x),Inches(y),Inches(w),Inches(h));sh.fill.solid();sh.fill.fore_color.rgb=PALE;sh.line.color.rgb=LINE st=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(x),Inches(y),Inches(.08),Inches(h));st.fill.solid();st.fill.fore_color.rgb=ac;st.line.fill.background() text(s,hd,x+.2,y+.15,w-.3,.24,14,NAVY,True);text(s,bd,x+.2,y+.49,w-.35,h-.58,11.2,INK) def bullets(s,items,refs): y=1.75 for b in items: dot=s.shapes.add_shape(MSO_SHAPE.OVAL,Inches(.68),Inches(y+.06),Inches(.16),Inches(.16));dot.fill.solid();dot.fill.fore_color.rgb=TEAL;dot.line.fill.background();text(s,b,.98,y,11.6,.5,14,INK);y+=.72 src(s,refs) def table(s,headers,rows, widths, fs=8.6): x=.48;y=1.65 for w,h in zip(widths,headers): sh=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(x),Inches(y),Inches(w),Inches(.45));sh.fill.solid();sh.fill.fore_color.rgb=NAVY;sh.line.fill.background();text(s,h,x+.04,y+.11,w-.08,.2,fs,WHITE,True,a=PP_ALIGN.CENTER);x+=w for r,row in enumerate(rows): x=.48;y=2.1+r*.48 for c,v in enumerate(row): sh=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(x),Inches(y),Inches(widths[c]),Inches(.47));sh.fill.solid();sh.fill.fore_color.rgb=PALE if r%2==0 else WHITE;sh.line.color.rgb=LINE;text(s,v,x+.04,y+.06,widths[c]-.08,.36,fs,INK,c==0);x+=widths[c] # slide 23 s=prs.slides.add_slide(blank);bg(s,'Psychometric properties: standard framework','“Psychometric properties” and “measurement properties” are used interchangeably in this seminar.','PSYCHOMETRICS') bullets(s,[ 'A measurement property is a quality aspect of an outcome measurement instrument. COSMIN groups these into reliability, validity and responsiveness.', 'Reliability concerns reproducibility when the patient has not truly changed. It includes reliability and measurement error.', 'Validity concerns whether the score supports the intended interpretation. It includes content validity, construct validity and criterion validity.', 'Responsiveness concerns whether a change score represents change in the intended construct over time.', 'Interpretability and feasibility are not measurement properties, but determine whether scores can be meaningfully and practically used.' ],[2,3,4,6]) # 24 detailed definitions s=prs.slides.add_slide(blank);bg(s,'Psychometric properties: detailed definitions','For every property, specify the population, version, administration method and intended purpose.','PSYCHOMETRICS') box(s,.62,1.78,3.9,1.65,'Reliability','The proportion of total score variance attributable to true differences among patients rather than measurement error. [2,4]',TEAL) box(s,4.72,1.78,3.9,1.65,'Measurement error','Systematic and random error in a score that is not attributable to true change. Express with SEM, SDC or MDC. [2,4]',GOLD) box(s,8.82,1.78,3.9,1.65,'Content validity','Degree to which instrument content adequately reflects the construct to be measured. [2,6]',GREEN) box(s,.62,4.05,3.9,1.65,'Structural validity','Degree to which scores adequately reflect the dimensionality of the construct. Evaluated with factor analysis or Rasch analysis. [2,6]',RED) box(s,4.72,4.05,3.9,1.65,'Construct validity','Degree to which scores agree with hypotheses based on the assumption that the measure validly measures the construct. [2,3]',TEAL) box(s,8.82,4.05,3.9,1.65,'Criterion validity','Degree to which scores adequately reflect a gold standard. A gold standard is often absent for disability constructs. [2,3]',GOLD) src(s,[2,3,4,6]) # 25 stats s=prs.slides.add_slide(blank);bg(s,'How to read psychometric statistics','Do not select a scale from one statistic alone. Appraise study design, 95% confidence interval and clinical context.','PSYCHOMETRICS') rows=[('Inter-rater / test-retest','ICC for continuous total scores; weighted kappa for ordinal ratings','Higher agreement is desirable; ICC ≥0.90 is commonly preferred for individual decisions.','[4,5]'),('Internal consistency','Cronbach alpha, preferably with structural evidence','0.70-0.95 may be adequate only if items form a unidimensional scale.','[3,6]'),('Measurement error','SEM; MDC/SDC','Change must exceed error (MDC/SDC) before it can be distinguished from random variation.','[3,4]'),('Construct validity','Correlation / group-difference hypotheses','Pre-specify expected direction and magnitude; confirmation supports validity.','[2,3]'),('Responsiveness','Hypothesis testing of change, AUC, effect indices','A change score needs evidence that it tracks actual construct change.','[2,3]'),('Floor / ceiling effects','Proportion at minimum or maximum score','Large clustering at extremes can reduce ability to distinguish severity or change.','[3,4]')] table(s,['Property','Typical analysis','Practical interpretation','Ref'],rows,[2.15,3.25,6.55,.72],9.2);src(s,[2,3,4,5,6]) # 26 criteria s=prs.slides.add_slide(blank);bg(s,'Detailed appraisal: reliability, error and responsiveness','Use this sequence before declaring a patient has “improved”.','PSYCHOMETRICS') box(s,.65,1.75,3.75,3.75,'1. Is the condition stable?','For test-retest studies, choose an interval long enough to avoid recall but short enough that true clinical change is unlikely. Verify stability using a global rating or clinical criterion.',TEAL) box(s,4.78,1.75,3.75,3.75,'2. Is agreement measured correctly?','Correlation alone measures association, not agreement. Use ICC for continuous scores, weighted kappa for ordered categories, and report 95% CI.',GOLD) box(s,8.9,1.75,3.75,3.75,'3. Is change larger than error?','Calculate or obtain SEM/MDC. If score change does not exceed MDC, it may be random error. If it exceeds MDC, it is real change but may still not be clinically important.',GREEN) text(s,'MDC/SDC = statistical “real change”; MCID/MIC = patient-important change. They answer different questions.',.9,5.88,11.5,.35,15,RED,True,a=PP_ALIGN.CENTER);src(s,[2,3,4,5,6]) # catalogue tables scales1=[('mRS','Stroke','Overall disability/dependence','Global disability','IRR/construct evidence; interview method matters','[8,9]'),('Barthel Index','Stroke, general rehab','Feeding, bathing, transfers, mobility, continence','Basic ADL/activity','Excellent stroke IRR in review; ceiling/floor risk','[10-12]'),('FIM','Neurorehabilitation','Self-care, sphincter, transfers, locomotion, communication, social cognition','Motor + cognition/activity','Inter-rater evidence; training/standardisation required','[13,14]'),('FAM','Brain injury','FIM plus communication, psychosocial, cognition','Activity + cognition/participation','Use with FIM context; confirm local version evidence','[13,23]'),('DRS','TBI','Arousal, cognitive ability, dependence, employability','Global disability/participation','Content spans recovery continuum; ordinal scale','[15]'),('GOS/GOSE','TBI','Survival, independence, work/social recovery','Global recovery/participation','Structured interview improves consistency','[16,17]'),('WHODAS 2.0','Cross-condition','Cognition, mobility, self-care, getting along, life activities, participation','Activity + participation','ICF-compatible; reliability/validity evidence varies by population','[18,24]'),('Stroke Impact Scale','Stroke','Strength, hand function, ADL, mobility, communication, emotion, participation','Multi-domain stroke impact','Validate selected version/language in target setting','[25]')] s=prs.slides.add_slide(blank);bg(s,'Scale catalogue I: broad and stroke/TBI measures','“Psychometric evidence” column is a guide to what must be checked, not a universal quality rating.','SCALE CATALOGUE') table(s,['Scale','Main population','Domains covered','ICF emphasis','Psychometric note','Ref'],scales1,[1.2,1.45,2.75,1.35,5.15,.72],7.8);src(s,[8,9,10,11,12,13,14,15,16,17,18,24,25]) scales2=[('Katz ADL','General / older neuro pts','Bathing, dressing, toileting, transfer, continence, feeding','Basic ADL','Brief; check responsiveness for your setting','[26]'),('Lawton IADL','Community-dwelling adults','Telephone, shopping, food, housekeeping, transport, medicines, finances','Instrumental ADL','Useful for community function; sex/cultural roles may affect interpretation','[27]'),('Frenchay Activities Index','Stroke','Domestic, leisure and outdoor activities','Participation/activity','Designed for social lifestyle activities after stroke','[28]'),('Rivermead Mobility Index','Neurorehab','Bed mobility to running','Mobility activity','Mobility-specific, not global disability','[29]'),('EDSS','Multiple sclerosis','Functional systems and ambulation','MS disability','Ambulation-weighted; ordinal, non-linear steps','[19]'),('MSIS-29','Multiple sclerosis','Physical and psychological impact','Patient-reported impact','Check version/language measurement evidence','[30]'),('MDS-UPDRS','Parkinson disease','Non-motor daily living, motor daily living, motor examination, complications','Motor + non-motor impact','Clinimetric testing published; disease-specific','[20]'),('Schwab & England ADL','Parkinson disease','Percentage independence in daily living','Global ADL','Coarse percentage ratings; pair with detailed domains','[31]')] s=prs.slides.add_slide(blank);bg(s,'Scale catalogue II: ADL, mobility, MS and Parkinson disease','These measures are commonly encountered in neuro-physiotherapy but do not all measure “global disability” in the same way.','SCALE CATALOGUE') table(s,['Scale','Main population','Domains covered','ICF emphasis','Psychometric note','Ref'],scales2,[1.2,1.45,2.75,1.35,5.15,.72],7.8);src(s,[19,20,26,27,28,29,30,31]) scales3=[('ALSFRS-R','ALS','Bulbar, fine motor, gross motor, respiratory function','Disease-specific function','Respiratory function added in revised scale','[21]'),('SCIM III','Spinal cord injury','Self-care, respiration/sphincter, mobility','Independence/activity','SCI-specific; item profile guides treatment','[22,32]'),('WISCI II','Spinal cord injury','Walking assistance, braces, devices','Walking activity','Walking-specific, not whole disability','[33]'),('Spinal Cord Independence Measure','Spinal cord injury','Self-care, respiration/sphincter, indoor/outdoor mobility','Multi-domain independence','Same construct as SCIM; use current version/manual','[22,32]'),('PDQ-39','Parkinson disease','Mobility, ADL, emotional well-being, stigma, social support, cognition, communication, pain','Participation/QoL impact','PROM, not a performance test','[34]'),('SARA','Ataxia','Gait, stance, sitting, speech, limb coordination','Ataxia impairment/activity','Disease-specific severity; not global disability','[35]'),('CPCHILD','Severe cerebral palsy','Personal care, positioning, comfort, communication, health, QoL','Care/participation','Caregiver-reported; paediatric context','[36]'),('PEDI-CAT','Children incl. neurodisability','Daily activities, mobility, social/cognitive, responsibility','Activity + participation','Age-referenced CAT; use licence/manual','[37]')] s=prs.slides.add_slide(blank);bg(s,'Scale catalogue III: SCI, ALS, ataxia and paediatric measures','A maximum practical list: not exhaustive. Always confirm the latest authorised version and population-specific evidence.','SCALE CATALOGUE') table(s,['Scale','Main population','Domains covered','ICF emphasis','Psychometric note','Ref'],scales3,[1.2,1.45,2.75,1.35,5.15,.72],7.8);src(s,[21,22,32,33,34,35,36,37]) # selection detailed s=prs.slides.add_slide(blank);bg(s,'Five scales selected for detailed explanation','Each selected scale covers more than two functional domains. “More domains” does not automatically mean “better”.','DETAILED SCALES') rows=[('FIM','6 domains; motor + cognitive tasks','Clinician-rated; 18 items; 1-7/item; total 18-126','Rehab dependency / burden of care','[13,14]'),('WHODAS 2.0','6 domains: cognition, mobility, self-care, getting along, life, participation','12 or 36 items; self/proxy/interviewer formats','Cross-condition activity and participation','[18,24]'),('SCIM III','3 domains: self-care, respiration/sphincter, mobility','SCI-specific independence profile','SCI rehabilitation planning','[22,32]'),('MDS-UPDRS','4 parts: non-motor ADL, motor ADL, motor exam, motor complications','Patient + clinician components','Parkinson multi-domain monitoring','[20]'),('DRS','8 items across arousal, cognition, dependence, psychosocial adaptation/employability','Clinician-rated ordinal items','TBI recovery continuum','[15]')] table(s,['Scale','>2 domains','Format / score','Best clinical purpose','Ref'],rows,[1.25,3.0,3.35,4.85,.72],9);src(s,[13,14,15,18,20,22,24,32]) # Detailed each for title, sub, domains, use, psych, refs in [ ('Functional Independence Measure (FIM)','A clinician-rated measure of disability/dependence across 18 functional tasks.','Self-care; sphincter control; transfers; locomotion; communication; social cognition. Thirteen motor and five cognitive items are rated from 1 (total assistance) to 7 (complete independence).','Use: rehabilitation description, assistance planning and serial tracking of independence. Report motor and cognitive scores when possible, not only total.','Psychometric appraisal: inter-rater reliability requires a standard scoring protocol and trained raters. Because the total is ordinal-derived and includes varied tasks, interpret score changes alongside item-level changes and measurement error.','[13,14,24]'), ('WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)','An ICF-compatible measure of disability across six activity and participation domains.','Understanding/communicating; getting around; self-care; getting along; life activities; participation. Available in 12-item and 36-item formats; may be self-administered, interviewer-administered or proxy completed.','Use: broad cross-condition disability and participation perspective, including community and social impact not captured by basic ADL scales.','Psychometric appraisal: content is intentionally broad and ICF-linked. Reliability, construct validity and responsiveness must be checked for the specific language, respondent type, neurological diagnosis and format used.','[18,24]'), ('Spinal Cord Independence Measure (SCIM)','A spinal cord injury-specific independence measure designed around the functional consequences of SCI.','Self-care; respiration and sphincter management; indoor/outdoor mobility including transfers. The item profile makes the source of dependence visible.','Use: SCI rehabilitation goal setting, monitoring and communication of functional independence. Prefer it to generic scales when SCI-specific tasks are central.','Psychometric appraisal: evaluate the version (for example, SCIM III), rater training, completeness and score interpretation. It is disease-specific, so cross-condition comparison with mRS or WHODAS is inappropriate.','[22,32]'), ('Movement Disorder Society-UPDRS (MDS-UPDRS)','A Parkinson disease-specific scale with patient-reported and examiner-rated components.','Part I: non-motor experiences of daily living; Part II: motor experiences of daily living; Part III: motor examination; Part IV: motor complications.','Use: Parkinson disease monitoring when both daily-life impact and motor examination are relevant. It is not a generic global disability endpoint.','Psychometric appraisal: clinimetric testing is reported for the revised scale. Standardised timing in relation to medication state, examiner technique and part-specific reporting are needed for meaningful follow-up.','[20]'), ('Disability Rating Scale (DRS)','A broad scale created for severe traumatic brain injury, from coma through community reintegration.','Arousability/awareness; cognitive ability for self-care; dependence on others; psychosocial adaptability and employability. It spans impairment, activity and social role consequences.','Use: describe recovery trajectory after moderate-to-severe TBI where level of consciousness and long-term disability both matter.','Psychometric appraisal: the ordinal score summarizes diverse domains. Pair it with detailed cognitive, mobility and participation measures when those treatment targets need precision. Maintain consistent rater definitions.','[15,23]')]: s=prs.slides.add_slide(blank);bg(s,title,sub,'DETAILED SCALES') box(s,.65,1.72,3.75,3.9,'Domains covered',domains,TEAL) box(s,4.78,1.72,3.75,3.9,'Clinical use',use,GOLD) box(s,8.9,1.72,3.75,3.9,'Psychometric interpretation',psych,GREEN) src(s,[int(x) for x in refs.replace('[','').replace(']','').split(',')]) # final implementation s=prs.slides.add_slide(blank);bg(s,'How to present psychometric evidence in your seminar','Use cautious language: evidence is version-, population- and purpose-specific.','APPLICATION') bullets(s,[ 'Say: “The Barthel Index showed excellent inter-rater reliability with standard administration in stroke cohorts” rather than “The Barthel Index is always reliable”.', 'Say: “A scale has evidence supporting construct validity for this population” rather than “the scale is valid”.', 'Report the statistic, 95% CI, study population, administration method and interval when presenting reliability evidence.', 'Never treat a score change as clinically important only because it is statistically different. Compare it with MDC/SDC and, where available, MIC/MCID.', 'Use a global scale to communicate overall status and a domain-specific measure to guide physiotherapy treatment targets.' ],[2,3,4,5,6,9,12,23,24]) # refs additions refs=[ '23. Hall KM, Mann N, High WM, Wright J, Kreutzer JS, Wood D. Functional measures after traumatic brain injury: ceiling effects of FIM, FIM+FAM, DRS, and CIQ. J Head Trauma Rehabil. 1996;11(5):27-39.', '24. World Health Organization. Measuring health and disability: manual for WHO Disability Assessment Schedule WHODAS 2.0. Geneva: WHO; 2010.', '25. Duncan PW, Bode RK, Min Lai S, Perera S. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84(7):950-63.', '26. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: the index of ADL. JAMA. 1963;185:914-9.', '27. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-86.', '28. Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing. 1983;12(2):166-70.', '29. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud. 1991;13(2):50-4.', '30. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001;124(Pt 5):962-73.', '31. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson IM, editors. Third symposium on Parkinson’s disease. Edinburgh: E & S Livingstone; 1969. p. 152-7.', '32. Itzkovich M, Gelernter I, Biering-Sørensen F, Weeks C, Laramee MT, Craven BC, et al. The Spinal Cord Independence Measure (SCIM) version III: reliability and validity in a multi-center international study. Disabil Rehabil. 2007;29(24):1926-33.', '33. Dittuno PL, Dittuno JF. Walking index for spinal cord injury (WISCI II): scale revision. Spinal Cord. 2001;39(12):654-6.', '34. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res. 1995;4(3):241-8.', '35. Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717-20.', '36. Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006;48(10):804-12.', '37. Haley SM, Coster WJ, Dumas HM, Fragala-Pinkham MA, Moed R. PEDI-CAT: development, standardization and administration manual. Boston: CREcare; 2011.' ] s=prs.slides.add_slide(blank);bg(s,'Additional references (23-30)','Vancouver style','REFERENCES') y=1.58 for r in refs[:8]: text(s,r,.65,y,12,.32,9.5,INK);y+=.55 src(s,list(range(23,31))) s=prs.slides.add_slide(blank);bg(s,'Additional references (31-37)','Vancouver style','REFERENCES') y=1.58 for r in refs[8:]: text(s,r,.65,y,12,.32,9.5,INK);y+=.55 src(s,list(range(31,38))) prs.save(OUT) print(OUT, len(prs.slides)) ''') PY python "/tmp/workspace/neuro-global-disability-ppt/src/append_detailed_content.py"

Running Command

python - <<'PY' from pptx import Presentation p='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability_DETAILED.pptx' prs=Presentation(p) # New additions are 26-40. Update citations only on append slides where those new publications are cited. updates={ 26:'Sources: [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [26], [27], [28]', 27:'Sources: [19], [20], [29], [30], [31], [32], [33], [34]', 28:'Sources: [21], [22], [35], [36], [37], [38], [39], [40]', 29:'Sources: [13], [14], [15], [18], [20], [22], [27], [35]', 30:'Sources: [13], [14]', 31:'Sources: [18], [27]', 32:'Sources: [22], [35]', 33:'Sources: [20]', 34:'Sources: [15]', } # slide numbers human-facing, to index for num,new in updates.items(): slide=prs.slides[num-1] for sh in slide.shapes: if getattr(sh,'has_text_frame',False) and sh.text.startswith('Sources:'): sh.text_frame.paragraphs[0].runs[0].text=new # set post replacement font reliably for r in sh.text_frame.paragraphs[0].runs: r.font.name='Aptos'; r.font.size=Pt(8); r.font.color.rgb=RGBColor(255,255,255) # Fix added reference slide entries 36 to 38 numbering labels. for slide_num, start in [(36,26),(37,34)]: slide=prs.slides[slide_num-1] for sh in slide.shapes: if getattr(sh,'has_text_frame',False): tx=sh.text # exact visible entries currently start 23... or 31... for old,new in [(str(i)+'.',str(i+3)+'.') for i in range(23,38)]: if tx.startswith(old): for r in sh.text_frame.paragraphs[0].runs: r.text=r.text.replace(old,new,1) break # Fix citations in footer for sh in slide.shapes: if getattr(sh,'has_text_frame',False) and sh.text.startswith('Sources:'): nums=range(26,34) if slide_num==36 else range(34,41) sh.text_frame.paragraphs[0].runs[0].text='Sources: '+', '.join(f'[{n}]' for n in nums) for r in sh.text_frame.paragraphs[0].runs: r.font.name='Aptos';r.font.size=Pt(8);r.font.color.rgb=RGBColor(255,255,255) prs.save(p) print('fixed') PY python - <<'PY' from pptx import Presentation import os p='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability_DETAILED.pptx' prs=Presentation(p) print('slides',len(prs.slides),'bytes',os.path.getsize(p)) for i in range(22,len(prs.slides)): lines=[] for sh in prs.slides[i].shapes: if getattr(sh,'has_text_frame',False) and sh.text.startswith('Sources:'): lines.append(sh.text) print(i+1,lines) PY

Running Command

python - <<'PY' from pptx import Presentation from pptx.util import Pt from pptx.dml.color import RGBColor p='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability_DETAILED.pptx' prs=Presentation(p) # Correct added-reference numbering in detailed additions. Original deck references 1-25; additions begin 26. map_old_new={'[25]':'[28]','[26]':'[29]','[27]':'[30]','[28]':'[31]','[29]':'[32]','[30]':'[33]','[31]':'[34]','[32]':'[35]','[33]':'[36]','[34]':'[37]','[35]':'[38]','[36]':'[39]','[37]':'[40]'} # only content slides 27 through 34, retain intentional original [23],[24] elsewhere. for si in range(26,34): for sh in prs.slides[si].shapes: if not getattr(sh,'has_text_frame',False): continue old=sh.text new=old # reverse avoids cascades for a,b in reversed(list(map_old_new.items())): new=new.replace(a,b) if new != old: # reconstruct preserving simple textbox format p0=sh.text_frame.paragraphs[0] if p0.runs: p0.runs[0].text=new for r in p0.runs[1:]: r.text='' else: p0.text=new # Explicit complete source footers foot={ 27:'Sources: [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [28]', 28:'Sources: [19], [20], [29], [30], [31], [32], [33], [34]', 29:'Sources: [21], [22], [35], [36], [37], [38], [39], [40]', 30:'Sources: [13], [14], [15], [18], [20], [22], [27], [35]', 31:'Sources: [13], [14]', 32:'Sources: [18], [27]', 33:'Sources: [22], [35]', 34:'Sources: [20]', 35:'Sources: [15], [23]', } for sn, val in foot.items(): for sh in prs.slides[sn-1].shapes: if getattr(sh,'has_text_frame',False) and sh.text.startswith('Sources:'): p0=sh.text_frame.paragraphs[0] if p0.runs: p0.runs[0].text=val for r in p0.runs[1:]:r.text='' else:p0.text=val for r in p0.runs: r.font.name='Aptos';r.font.size=Pt(8);r.font.color.rgb=RGBColor(255,255,255) # Correct labels on the last two reference slides for sn in (37,38): for sh in prs.slides[sn-1].shapes: if getattr(sh,'has_text_frame',False): tx=sh.text if sn==37: for old,new in zip(range(23,31),range(26,34)): if tx.startswith(f'{old}.'): sh.text_frame.paragraphs[0].runs[0].text=tx.replace(f'{old}.',f'{new}.',1);break else: for old,new in zip(range(31,38),range(34,41)): if tx.startswith(f'{old}.'): sh.text_frame.paragraphs[0].runs[0].text=tx.replace(f'{old}.',f'{new}.',1);break # Footer source labels for refs for sn, nums in [(37,range(26,34)),(38,range(34,41))]: for sh in prs.slides[sn-1].shapes: if getattr(sh,'has_text_frame',False) and sh.text.startswith('Sources:'): sh.text_frame.paragraphs[0].runs[0].text='Sources: '+', '.join(f'[{n}]' for n in nums) prs.save(p) print('saved',p) PY python - <<'PY' from pptx import Presentation import os p='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability_DETAILED.pptx' prs=Presentation(p) print('slides=',len(prs.slides),'bytes=',os.path.getsize(p)) missing=[] for i,slide in enumerate(prs.slides,1): found=any(getattr(sh,'has_text_frame',False) and sh.text.startswith('Sources:') for sh in slide.shapes) if not found: missing.append(i) print('slides without source footer:',missing) for n in range(27,39): f=[sh.text for sh in prs.slides[n-1].shapes if getattr(sh,'has_text_frame',False) and sh.text.startswith('Sources:')] print(n,f[0] if f else '') PY

Expanded the presentation to 38 slides with stricter reference coverage.
New content includes:
  • Detailed, standard definitions of psychometric properties
  • Reliability, measurement error, validity, responsiveness, interpretability, feasibility, floor and ceiling effects
  • Detailed explanation of ICC, weighted kappa, Cronbach alpha, SEM, MDC/SDC, and MCID/MIC
  • Three scale-catalogue tables covering a broad range of neurological outcome measures
  • For each listed scale: target population, domains covered, ICF emphasis, and psychometric considerations
  • Detailed explanation of five multi-domain measures:
    1. Functional Independence Measure (FIM)
    2. WHODAS 2.0
    3. Spinal Cord Independence Measure (SCIM)
    4. MDS-UPDRS
    5. Disability Rating Scale (DRS)
  • Expanded Vancouver reference section, now including 40 numbered references
  • Citation footer on every slide

Outcome Measures Neurophysiotherapy Global Disability DETAILED

Presentation · PPTX

Make a PDF handout with the five scales’ psychometrics and arrange all the slides and explain each slide in detail

Reading File
Reading File
Reading File
Browsing Directory

~/

Searching the Web

FIM WHODAS SCIM MDS-UPDRS Disability Rating Scale psychometric properties reliability validity systematic review

Searching PubMed

Functional Independence Measure reliability validity rehabilitation

Searching PubMed

WHODAS 2.0 reliability validity neurological rehabilitation

Searching PubMed

SCIM III reliability validity spinal cord injury

Searching PubMed

MDS-UPDRS psychometric properties reliability validity

Searching PubMed

Disability Rating Scale reliability validity traumatic brain injury

Running Command

python - <<'PY' from pptx import Presentation from pathlib import Path p=Path('/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_Global_Disability_DETAILED.pptx') prs=Presentation(str(p)) out=[] for i,sl in enumerate(prs.slides,1): tx=[] for sh in sl.shapes: if getattr(sh,'has_text_frame',False) and sh.text.strip(): tx.append(sh.text.strip().replace('\n',' | ')) out.append(f'SLIDE {i}\n'+'\n'.join(tx)+'\n') Path('/tmp/workspace/neuro-global-disability-ppt/src/slides_extract.txt').write_text('\n'.join(out)) print('written',len(prs.slides)) PY

Running Command

python - <<'PY' from pathlib import Path p=Path('/tmp/workspace/neuro-global-disability-ppt/src/create_handout.py') p.write_text(r'''from reportlab.lib.pagesizes import A4 from reportlab.lib import colors from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.lib.enums import TA_CENTER, TA_LEFT from reportlab.lib.units import cm from reportlab.platypus import SimpleDocTemplate, Paragraph, Spacer, PageBreak, Table, TableStyle, KeepTogether from reportlab.pdfbase.pdfmetrics import stringWidth from reportlab.lib.colors import HexColor OUT='/tmp/workspace/neuro-global-disability-ppt/output/Neurophysiotherapy_Global_Disability_Handout_and_Speaker_Notes.pdf' NAVY=HexColor('#122D4B'); TEAL=HexColor('#007E87'); GOLD=HexColor('#F5B43C'); PALE=HexColor('#F4F8FA'); INK=HexColor('#1F2B36'); MUTED=HexColor('#5B6976'); RED=HexColor('#B43D41') styles=getSampleStyleSheet() styles.add(ParagraphStyle(name='Title2',parent=styles['Title'],fontName='Helvetica-Bold',fontSize=22,leading=28,textColor=NAVY,alignment=TA_CENTER,spaceAfter=12)) styles.add(ParagraphStyle(name='Sub',parent=styles['Normal'],fontName='Helvetica',fontSize=11,leading=15,textColor=MUTED,alignment=TA_CENTER,spaceAfter=16)) styles.add(ParagraphStyle(name='H1x',parent=styles['Heading1'],fontName='Helvetica-Bold',fontSize=16,leading=20,textColor=NAVY,spaceBefore=12,spaceAfter=7)) styles.add(ParagraphStyle(name='H2x',parent=styles['Heading2'],fontName='Helvetica-Bold',fontSize=12.5,leading=16,textColor=TEAL,spaceBefore=8,spaceAfter=5)) styles.add(ParagraphStyle(name='Bodyx',parent=styles['BodyText'],fontName='Helvetica',fontSize=9.4,leading=13,textColor=INK,spaceAfter=6)) styles.add(ParagraphStyle(name='Small',parent=styles['BodyText'],fontName='Helvetica',fontSize=7.5,leading=9.5,textColor=INK,spaceAfter=3)) styles.add(ParagraphStyle(name='Note',parent=styles['BodyText'],fontName='Helvetica-Oblique',fontSize=8.7,leading=12,textColor=MUTED,spaceAfter=7)) styles.add(ParagraphStyle(name='SlideN',parent=styles['Heading2'],fontName='Helvetica-Bold',fontSize=11.5,leading=14,textColor=NAVY,spaceBefore=7,spaceAfter=3)) def P(t,sty='Bodyx'): return Paragraph(t,styles[sty]) def bullets(items): return [P('• '+x) for x in items] def footer(canvas,doc): canvas.saveState();canvas.setStrokeColor(TEAL);canvas.line(1.55*cm,1.25*cm,19.45*cm,1.25*cm);canvas.setFont('Helvetica',7.5);canvas.setFillColor(MUTED);canvas.drawString(1.55*cm,.83*cm,'Neuro-physiotherapy outcome measures: global disability handout');canvas.drawRightString(19.45*cm,.83*cm,f'Page {doc.page}');canvas.restoreState() doc=SimpleDocTemplate(OUT,pagesize=A4,rightMargin=1.55*cm,leftMargin=1.55*cm,topMargin=1.45*cm,bottomMargin=1.6*cm) story=[] story += [Spacer(1,1.0*cm),P('Outcome Measures Used in Neuro-Physiotherapy','Title2'),P('Global measures of disability: detailed handout, five-scale psychometric summary, and slide-by-slide speaker notes','Sub')] story += [P('<b>Purpose.</b> This handout accompanies the 38-slide seminar. It explains the intended message of every slide and provides a focused psychometric appraisal of five multi-domain measures: Functional Independence Measure (FIM), WHODAS 2.0, Spinal Cord Independence Measure (SCIM III), MDS-UPDRS, and Disability Rating Scale (DRS).','Bodyx')] story += [P('<b>How to use it.</b> Read the bold “Speaker explanation” under each slide before presenting. References in square brackets refer to the Vancouver reference list at the end. Measurement evidence applies only to the named version, population, language, rater/respondent, administration method, and setting.','Note')] story += [P('Learning outcomes','H1x')]+bullets(['Explain outcome measures, domains, global disability and ICF framing.','Distinguish reliability, measurement error, validity, responsiveness, interpretability and feasibility.','Select and interpret a global disability measure without claiming that one total score explains every functional problem.']) story += [P('Important terminology','H1x')] terms=[['Term','Working definition'],['Outcome measure','A standardised instrument, test, rating scale or questionnaire used to quantify a health-related construct at one or more time points.'],['Domain','A distinct component of the construct measured, such as self-care, mobility, communication or participation.'],['Global disability measure','A broad summary of functional consequence, dependence or disability burden. It may combine several domains or use a global clinical judgement.'],['Psychometric property','A quality aspect of an instrument’s scores, usually described under reliability, validity and responsiveness.']] t=Table([[P(c,'Small') for c in r] for r in terms],colWidths=[4.0*cm,14.0*cm]);t.setStyle(TableStyle([('BACKGROUND',(0,0),(-1,0),NAVY),('TEXTCOLOR',(0,0),(-1,0),colors.white),('FONTNAME',(0,0),(-1,0),'Helvetica-Bold'),('GRID',(0,0),(-1,-1),.25,HexColor('#C8D7DE')),('BACKGROUND',(0,1),(-1,-1),PALE),('VALIGN',(0,0),(-1,-1),'TOP'),('LEFTPADDING',(0,0),(-1,-1),5),('RIGHTPADDING',(0,0),(-1,-1),5),('TOPPADDING',(0,0),(-1,-1),5),('BOTTOMPADDING',(0,0),(-1,-1),5)]));story += [t,Spacer(1,8),P('Definitions adapted from the ICF and COSMIN taxonomy. [1-4]','Small'),PageBreak()] story += [P('Five selected multi-domain scales: concise psychometric comparison','H1x')] summary=[['Scale','Domains / format','Reliability and error','Validity / responsiveness','Practical interpretation'],['FIM','18 items: 13 motor, 5 cognitive; clinician rated.','Inter-rater agreement is reported with standardised scoring; rater training is central. [12,13]','Content spans burden of care; total score combines different tasks. Examine motor/cognitive and item scores. [12-14]','Use for rehabilitation dependence. Do not interpret total score as participation or quality of life.'],['WHODAS 2.0','6 domains; 12- or 36-item, self/interviewer/proxy formats.','Evidence differs by form, language, respondent and population. Do not transfer one version’s reliability to another. [17,18]','ICF-compatible content supports broad activity/participation assessment; construct evidence must match population. [17,18]','Useful for cross-condition disability and participation, but cognitive/language issues can affect self-report.'],['SCIM III','Self-care; respiration/sphincter; mobility; SCI-specific.','Multicentre reliability and validity evidence published for SCIM III. [20]','SCI-specific content supports relevance; use item profile rather than only total. [19,20]','Prefer when SCI-specific independence is the target.'],['MDS-UPDRS','4 parts: non-motor ADL, motor ADL, motor examination, motor complications.','Clinimetric testing exists for the revised scale; administration standardisation is required. [21]','Content captures motor and non-motor Parkinson impact; report parts separately. [21]','Record medication state and timing. It is disease-specific, not a generic disability scale.'],['DRS','8 ratings across arousal, cognition, dependence and psychosocial adaptation/employability.','Psychometric and clinical utility review supports use in TBI but the score is ordinal and broad. [14,22]','Spans recovery from coma to community; pair with targeted measures for detailed treatment decisions. [14,22]','Use for moderate-severe TBI trajectory, not as a detailed mobility or cognitive profile.']] t=Table([[P(c,'Small') for c in r] for r in summary],colWidths=[1.5*cm,3.25*cm,4.15*cm,4.15*cm,4.45*cm],repeatRows=1);t.setStyle(TableStyle([('BACKGROUND',(0,0),(-1,0),NAVY),('TEXTCOLOR',(0,0),(-1,0),colors.white),('FONTNAME',(0,0),(-1,0),'Helvetica-Bold'),('GRID',(0,0),(-1,-1),.25,HexColor('#C8D7DE')),('BACKGROUND',(0,1),(-1,-1),PALE),('VALIGN',(0,0),(-1,-1),'TOP'),('LEFTPADDING',(0,0),(-1,-1),3),('RIGHTPADDING',(0,0),(-1,-1),3),('TOPPADDING',(0,0),(-1,-1),4),('BOTTOMPADDING',(0,0),(-1,-1),4)]));story += [t,Spacer(1,8),P('<b>Safety point:</b> No generic hierarchy can label one scale “best”. A scale is appropriate only if its construct, population, rater/respondent, setting, language and decision match the intended use. [2-6]','Note'),PageBreak()] # detailed scales scales=[ ('1. Functional Independence Measure (FIM)','The FIM has 18 clinician-rated items: 13 motor and 5 cognitive. Each item is rated from 1 (total assistance) to 7 (complete independence), yielding a total from 18 to 126. It describes level of assistance and burden of care rather than isolated neurological impairment. [12,13]',['Reliability: use trained raters and the official scoring rules. Inter-rater reliability can be undermined when raters interpret assistance levels differently. [13]','Validity: the instrument samples self-care, sphincter control, transfers, locomotion, communication and social cognition. This broad content supports rehabilitation dependency assessment, but it does not directly measure participation or quality of life. [12,14]','Responsiveness and interpretation: show baseline and follow-up total, motor and cognitive values, plus the items that changed. A total-score gain should not be assumed to mean equal improvement in every domain. [14]','Feasibility: clinician observation and scoring training are required. Check institutional licensing and local policy before use.']), ('2. WHODAS 2.0','WHODAS 2.0 is an ICF-compatible disability measure available in 12-item and 36-item versions and self-, interviewer-, or proxy-administered formats. It assesses understanding/communicating, getting around, self-care, getting along, life activities and participation. [17]',['Reliability: distinguish the exact form. Internal consistency, test-retest and inter-rater findings may differ across 12-item versus 36-item versions, respondent type, language and clinical population. [18]','Validity: its six-domain content links closely to ICF activity and participation. Construct validity must be checked against an appropriate comparator and pre-specified hypotheses for the target group. [2,17]','Responsiveness: do not assume a short form is equally responsive to every intervention. Confirm evidence for the relevant neurological diagnosis and follow-up period. [2,18]','Feasibility: self-report can be difficult when cognition, communication, insight or literacy are impaired. Record whether self, proxy or interviewer completion was used. [17,18]']), ('3. Spinal Cord Independence Measure, version III (SCIM III)','SCIM III is an SCI-specific instrument covering self-care, respiration and sphincter management, and mobility indoors/outdoors. Its content is selected for independence problems commonly experienced after spinal cord injury. [19,20]',['Reliability: an international multicentre study reported reliability and validity findings for SCIM III. This supports use when the patient resembles the SCI population studied and the same administration rules are followed. [20]','Validity: disease-specific content offers a content-valid advantage over generic ADL scales where respiration, bowel/bladder management and wheelchair mobility are treatment priorities. [19,20]','Responsiveness/interpretation: inspect subscale and item scores. A stable total can conceal clinically relevant improvement in a single domain, and vice versa. Use an SCI-specific manual to define scoring. [19,20]','Feasibility: suitable for SCI rehabilitation, but requires knowledge of assistive technology, transfers and SCI care procedures.']), ('4. Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)','MDS-UPDRS is a Parkinson disease-specific scale with four parts: non-motor experiences of daily living, motor experiences of daily living, motor examination, and motor complications. It contains patient-reported and examiner-rated components. [21]',['Reliability: standardised wording, examiner technique and prescribed administration matter. The revised scale underwent clinimetric testing, but that does not remove the need for consistent local assessment. [21]','Validity: its structure deliberately separates motor and non-motor impact, examination and treatment complications. Therefore, part scores should be reported instead of relying only on a combined statement of severity. [21]','Responsiveness/interpretation: compare like with like. Record ON/OFF state, medication timing, dyskinesia state and assessor conditions because these can change observed performance. [21]','Feasibility: useful when Parkinson-specific monitoring is needed. It is not a generic scale for comparing disability across stroke, SCI and TBI.']), ('5. Disability Rating Scale (DRS)','DRS was developed for severe traumatic brain injury and spans the course from coma to community. Its 8 ratings address arousal/awareness, cognitive ability for self-care, dependence and psychosocial adaptability/employability. [14]',['Reliability: use defined rating anchors and a consistent rater process. The score is ordinal and aggregates heterogeneous functions, so changes should be interpreted carefully. [14,22]','Validity: its broad recovery continuum makes it clinically useful in TBI, but it does not provide a precise assessment of gait, upper-limb function, speech, cognition or community participation separately. [14,22]','Responsiveness/interpretation: it may describe major recovery stages. Pair DRS with domain-specific tools when a physiotherapy treatment target needs a sensitive, actionable outcome. [14,22]','Feasibility: relatively brief and applicable over a wide TBI severity range; ensure rater familiarity with the items and their anchors.'])] for h,definition,pts in scales: story += [P(h,'H1x'),P(definition,'Bodyx'),P('Psychometric interpretation','H2x')]+bullets(pts)+[P('Teaching sentence: “This scale has evidence for specific measurement properties in specified contexts. It should be selected because it fits the clinical question, not merely because it has many items.”','Note')] story += [PageBreak(),P('Slide-by-slide speaker notes','Title2'),P('These notes follow the arranged 38-slide deck. They provide an explanation to say aloud, not text to read word-for-word.','Sub')] notes=[ ('1. Title','Introduce the seminar as a method for choosing and interpreting outcome measures, not a list to memorise. Tell the audience that the focus is “global disability”, meaning broad functional consequence rather than a single impairment.'), ('2. Learning objectives','Explain that learners will move from basic measurement language to scale selection. State that reliability and validity are properties of score interpretation in a context, not permanent labels attached to a scale.'), ('3. What is an outcome measure?','Contrast the outcome, which is the patient’s status or change, with the outcome measure, which is the standardised tool used to quantify it. In neuro-physiotherapy, measures support baseline assessment, goal setting, monitoring and communication.'), ('4. Where does disability sit?','Use the ICF to separate body functions/structures, activity and participation. A weak ankle dorsiflexor is impairment; difficulty walking is activity limitation; inability to return to work can be participation restriction. Contextual factors modify all three.'), ('5. Global measures of disability','Define global disability as a broad summary of dependence or functional consequence. Warn that a global score can hide the specific source of disability, so it is often paired with domain-specific tests.'), ('6. Types of outcome measures','Explain the distinction between impairment, activity and global disability measures. Also distinguish clinician/performance ratings from patient-reported measures. A complete neuro-physiotherapy assessment often needs more than one type.'), ('7. Psychometric properties','Introduce the five practical ideas: reliability, validity, responsiveness, interpretability and feasibility. Explain that COSMIN classifies reliability, validity and responsiveness as measurement properties; feasibility and interpretability are essential practical considerations.'), ('8. Reliability: types','Define test-retest, inter-rater, intra-rater and internal consistency. Clarify that internal consistency applies only to multi-item scales intended to measure one construct and does not establish inter-rater agreement.'), ('9. How to judge reliability','Explain why ICC is generally used for continuous scores and weighted kappa for ordered categories. Correlation alone is not agreement. A high coefficient is insufficient without confidence intervals and measurement-error estimates.'), ('10. Validity: types','Define content validity, construct validity and criterion validity. Stress that disability rarely has a true gold standard, so criterion validity is often not available. Face validity is acceptability, not proof.'), ('11. How to judge validity','Teach the appraisal sequence: define construct, inspect content, test hypotheses/structure, match population and interpretability. Emphasise that validation evidence does not automatically transfer to a different language, diagnosis or setting.'), ('12. Feasibility and clinical utility','A tool must be usable in real practice. Discuss time, patient burden, cognitive/language needs, rater training, cost, licences and score interpretation. A very long instrument may be unsuitable in an acute, fatigued patient.'), ('13. Modified Rankin Scale','mRS is a single global ordinal outcome commonly used after stroke. Walk through the 0-6 categories. Its strength is brevity; its limitation is that it cannot identify the specific activity causing dependence. Structured interview reduces ambiguity.'), ('14. Barthel Index and FIM','Compare the BI as a 10-item basic ADL/dependence scale with FIM’s broader motor and cognitive coverage. Neither is a direct measure of participation. Make clear that totals are not automatically interchangeable.'), ('15. Other global or broad disability measures','Use this slide to show that disease and purpose determine choice: DRS/GOSE for TBI, WHODAS for cross-condition disability, EDSS for MS, and disease-specific scales for Parkinson disease, ALS or SCI.'), ('16. Comparison at a glance','Read the table horizontally: construct, format, fit and caution. The key message is that scores from different scales cannot be compared simply because all are called “disability” measures.'), ('17. Worked selection example','In stroke rehabilitation, use an ADL measure such as BI or FIM to identify assistance needs and an mRS when the team needs a brief global endpoint. Add a gait or balance measure when walking is the treatment target.'), ('18. Implementation checklist','Explain that consistent administration is part of measurement quality. Choose the tool before treatment, train raters, define timing, document missing items and use the same version at follow-up.'), ('19. Key take-home messages','Summarise: begin with the clinical question; pair broad and specific measures; separate reliability, validity and responsiveness; and interpret change carefully.'), ('20. References 1-13','State that these are foundational sources for ICF, COSMIN terminology, measurement methods and early core scales.'), ('21. References 14-25','State that these references support the TBI, WHODAS, disease-specific and comparative content. Encourage learners to locate the official manual for the exact version they plan to use.'), ('22. Questions','Invite questions that start with a clinical decision, such as “I need to document change in transfer assistance after SCI”. Then decide which construct and measure fit.'), ('23. Psychometric properties: standard framework','Return to COSMIN. Reliability asks about consistency under stability, validity asks whether scores support the intended meaning, and responsiveness asks whether change scores represent true construct change.'), ('24. Detailed definitions','Explain each definition. Measurement error is distinct from reliability: a measure can show high relative reliability in a heterogeneous group yet still have clinically large absolute error.'), ('25. How to read psychometric statistics','Describe each statistic in the table. Explain that ICC/kappa are relative agreement measures, SEM/MDC quantify error, and pre-specified hypotheses are needed for construct validity and responsiveness.'), ('26. Detailed appraisal: reliability, error and responsiveness','Use the three steps: confirm stability, quantify agreement, then compare observed change with measurement error. Explain MDC/SDC means change likely exceeds random error, whereas MIC/MCID concerns whether change matters to patients.'), ('27. Scale catalogue I','These are broad, stroke and TBI scales. Highlight that mRS is very global, BI/FIM focus on activity/dependence, DRS/GOSE relate to TBI recovery, and WHODAS provides activity/participation breadth.'), ('28. Scale catalogue II','Explain that Katz and Lawton identify basic and instrumental ADLs; Frenchay adds social lifestyle; Rivermead is mobility-specific; EDSS and MSIS-29 are MS measures; MDS-UPDRS and Schwab-England are Parkinson-specific.'), ('29. Scale catalogue III','Explain why SCI and ALS require disease-specific measures. SCIM captures SCI-relevant independence. WISCI is only walking. PDQ-39 is participation/quality-of-life related. SARA is ataxia severity, not a global disability scale.'), ('30. Five selected multi-domain scales','Introduce the five scales selected because each covers more than two domains. Explain that multi-domain coverage is useful when the clinical question is broad, but it can dilute sensitivity to one treatment target.'), ('31. FIM in detail','Describe the six FIM domains and the 1-7 assistance rating. For a physiotherapy plan, use the item profile to identify what assistance is required, then complement it with a gait, balance or strength measure if needed.'), ('32. WHODAS 2.0 in detail','Explain the six WHODAS domains and its ICF compatibility. It is particularly useful when participation and life activities matter. Document the version and whether self, proxy or interviewer completed it.'), ('33. SCIM III in detail','Explain that SCI-specific content is SCIM’s advantage. Its bladder/bowel, respiration and mobility items often reveal important independence goals that a generic scale may not represent well.'), ('34. MDS-UPDRS in detail','Explain the four parts and why medication state must be reported. Physiotherapy may be most interested in daily motor experience and examination, but non-motor impact can alter participation and adherence.'), ('35. DRS in detail','Explain the continuum from coma to community. DRS is suited to broad TBI outcome tracking but not enough for detailed physiotherapy prescription. Add targeted mobility, cognition or participation measures.'), ('36. How to present psychometric evidence','Model cautious wording. Say “showed excellent inter-rater reliability with standard administration in stroke cohorts”, rather than “is reliable”. Include method, population and confidence interval where known.'), ('37. Additional references 26-33','These references cover ADL, lifestyle, mobility, MS and SCI measures. Use them to identify the original instrument and then verify current authorised instructions.'), ('38. Additional references 34-40','These references cover Parkinson disease, ataxia and paediatric measures. End by reinforcing that the scale must fit the patient and decision.')] for title,note in notes: story += [P(title,'SlideN'),P('<b>Speaker explanation:</b> '+note,'Bodyx')] story += [PageBreak(),P('Vancouver references','H1x')] refs=[ '1. World Health Organization. International classification of functioning, disability and health: ICF. Geneva: WHO; 2001.', '2. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties. J Clin Epidemiol. 2010;63(7):737-45.', '3. Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42.', '4. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.', '5. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155-63.', '6. Mokkink LB, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, de Vet HCW, Terwee CB. COSMIN study design checklist for patient-reported outcome measurement instruments. Amsterdam: VU Medical Center; 2019.', '7. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2(5):200-15.', '8. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-7.', '9. Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393-5.', '10. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-5.', '11. Duffy L, Gajree S, Langhorne P, Stott DJ, Quinn TJ. Reliability (inter-rater agreement) of the Barthel Index for assessment of stroke survivors: systematic review and meta-analysis. Stroke. 2013;44(2):462-8.', '12. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.', '13. Hamilton BB, Laughlin JA, Fiedler RC, Granger CV. Interrater reliability of the 7-level Functional Independence Measure (FIM). Scand J Rehabil Med. 1994;26(3):115-9.', '14. Rappaport M, Hall KM, Hopkins K, Belleza T, Cope DN. Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil. 1982;63(3):118-23.', '15. Williams MW, Smith EL. Clinical utility and psychometric properties of the Disability Rating Scale with individuals with traumatic brain injury. Rehabil Psychol. 2017;62(3):339-45.', '16. Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15(8):573-85.', '17. Üstün TB, Kostanjsek N, Chatterji S, Rehm J, editors. Measuring health and disability: manual for WHO Disability Assessment Schedule WHODAS 2.0. Geneva: WHO; 2010.', '18. Federici S, Tosti A, Russo EA, et al. Measurement characteristics of WHODAS 2.0 and WHODAS-Child: a systematic review of global psychometric studies in specific populations since 2010. Front Psychiatry. 2026. PMID: 41669624.', '19. Catz A, Itzkovich M, Agranov E, Ring H, Tamir A. SCIM-spinal cord independence measure: a new disability scale for patients with spinal cord lesions. Spinal Cord. 1997;35(12):850-6.', '20. Itzkovich M, Gelernter I, Biering-Sørensen F, Weeks C, Laramee MT, Craven BC, et al. The Spinal Cord Independence Measure (SCIM) version III: reliability and validity in a multi-center international study. Disabil Rehabil. 2007;29(24):1926-33.', '21. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-70.', '22. Hall KM, Mann N, High WM, Wright J, Kreutzer JS, Wood D. Functional measures after traumatic brain injury: ceiling effects of FIM, FIM+FAM, DRS, and CIQ. J Head Trauma Rehabil. 1996;11(5):27-39.', '23. Playford ED. Outcome measurement in neurological disease. Curr Opin Neurol. 2008;21(4):461-6.', '24. Kwon S, Hartzema AG, Duncan PW, Min-Lai S. Disability measures in stroke: relationship among the Barthel Index, the Functional Independence Measure, and the Modified Rankin Scale. Stroke. 2004;35(4):918-23.', '25. Duncan PW, Bode RK, Min Lai S, Perera S. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84(7):950-63.', '26. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: the index of ADL. JAMA. 1963;185:914-9.', '27. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179-86.', '28. Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing. 1983;12(2):166-70.', '29. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud. 1991;13(2):50-4.', '30. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001;124(Pt 5):962-73.', '31. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson IM, editors. Third symposium on Parkinson’s disease. Edinburgh: E & S Livingstone; 1969. p. 152-7.', '32. Dittuno PL, Dittuno JF. Walking index for spinal cord injury (WISCI II): scale revision. Spinal Cord. 2001;39(12):654-6.', '33. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res. 1995;4(3):241-8.', '34. Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717-20.', '35. Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006;48(10):804-12.', '36. Haley SM, Coster WJ, Dumas HM, Fragala-Pinkham MA, Moed R. PEDI-CAT: development, standardization and administration manual. Boston: CREcare; 2011.' ] for r in refs: story.append(P(r,'Small')) doc.build(story,onFirstPage=footer,onLaterPages=footer) print(OUT) ''') PY python "/tmp/workspace/neuro-global-disability-ppt/src/create_handout.py"

Running Command

python - <<'PY' from pypdf import PdfReader p='/tmp/workspace/neuro-global-disability-ppt/output/Neurophysiotherapy_Global_Disability_Handout_and_Speaker_Notes.pdf' r=PdfReader(p) print('pages',len(r.pages)) for i in [0,1,2,len(r.pages)-2,len(r.pages)-1]: t=r.pages[i].extract_text() or '' print('PAGE',i+1,'chars',len(t),'start',repr(t[:180])) PY

Reading File
Created a 10-page PDF handout containing:
  • Detailed psychometric discussion of the five selected multi-domain scales:
    • FIM
    • WHODAS 2.0
    • SCIM III
    • MDS-UPDRS
    • Disability Rating Scale
  • Reliability, measurement error, validity, responsiveness, interpretation, and feasibility points for each scale
  • A concise comparison table for the five scales
  • Slide-by-slide speaker explanations for all 38 presentation slides
  • Vancouver-style reference list

Neurophysiotherapy Global Disability Handout and Speaker Notes

PDF Document · PDF

Seminar Topic Outcome Measures Used in Neuro-Physiotherapy: Global Measures of Disability Prepare a comprehensive, evidence-based postgraduate-level seminar PPT on the topic “Outcome Measures Used in Neuro-Physiotherapy – Global Measures of Disability.” The presentation should progress from basic concepts to advanced application and should use standard definitions, established outcome-measurement literature, original validation studies, systematic reviews, and authoritative textbooks/guidelines. PART 1 — FUNDAMENTALS OF OUTCOME MEASUREMENT Begin with the basic concept of outcome measurement. 1. What are Outcome Measures? Explain: * Definition of an outcome measure * Purpose of outcome measurement in physiotherapy * Importance of outcome measures in neuro-rehabilitation * Difference between: * Outcome measure * Assessment * Measurement * Evaluation * Clinical test * Scale/questionnaire * Why standardized outcome measures are required in clinical practice and research * Give at least 1 clinical neuro-physiotherapy example for each concept. Every factual statement should have an appropriate reference. 2. Classification/Types of Outcome Measures Explain the major classifications, including: * Impairment-based measures * Activity-based measures * Participation-based measures * Patient-reported outcome measures (PROMs) * Performance-based outcome measures * Clinician-reported measures * Generic/global measures * Disease-specific measures * Condition-specific measures Explain each with: * Standard definition * Purpose * Example from neuro-physiotherapy * Advantages and limitations ⸻ PART 2 — PSYCHOMETRIC PROPERTIES OF OUTCOME MEASURES Provide a detailed explanation of the major psychometric properties used to judge the quality of an outcome measure. For each psychometric property, provide: 1. Standard definition 2. What the property means clinically 3. Why it is important 4. Types/subcategories 5. Common statistical parameters used 6. How it is interpreted 7. What constitutes good/acceptable measurement quality 8. Clinical example from neuro-physiotherapy 9. Appropriate reference Cover at minimum: A. Reliability Explain: * Definition of reliability * Test–retest reliability * Inter-rater reliability * Intra-rater reliability * Internal consistency * Parallel/alternate-form reliability, where applicable Explain statistical indicators such as: * ICC * Kappa * Weighted kappa * Cronbach’s alpha * SEM * MDC Explain how to determine whether a scale has good reliability, including commonly accepted interpretation criteria and important limitations of relying only on ICC or Cronbach’s alpha. B. Validity Explain: * Definition of validity * Content validity * Face validity * Construct validity * Convergent validity * Divergent/discriminant validity * Known-groups validity * Criterion validity * Concurrent validity * Predictive validity Explain commonly reported statistics such as: * Pearson/Spearman correlation * Sensitivity * Specificity * ROC/AUC Explain how to determine whether a scale has good validity and clarify that validity is not simply a single numerical value. C. Responsiveness Explain: * Definition * Importance in rehabilitation * Ability of an instrument to detect clinically meaningful change * Effect size * Standardized response mean * MDC * MCID Explain the difference between: MDC vs MCID vs responsiveness. D. Feasibility Explain: * Definition * Administration time * Cost * Equipment requirements * Training requirements * Patient burden * Clinician burden * Accessibility * Scoring complexity Give examples of highly feasible versus less feasible neuro-rehabilitation measures. E. Other Important Measurement Properties Also explain, where applicable: * Interpretability * Floor effect * Ceiling effect * Measurement error * Precision * Cross-cultural validity * Structural validity * Hypothesis testing * Criterion validity Use recognized terminology from modern measurement literature. ⸻ PART 3 — HOW TO JUDGE WHETHER A SCALE IS “GOOD” Create a dedicated section titled: “How Do We Know Whether an Outcome Measure Is Good?” Explain systematically how a physiotherapist should critically appraise an outcome measure. Include a checklist covering: 1. Reliability 2. Validity 3. Responsiveness 4. Measurement error 5. MDC 6. MCID 7. Feasibility 8. Interpretability 9. Floor/ceiling effects 10. Population-specific validation 11. Cultural/language validation 12. Appropriate reference standards Explain an important principle: A scale should not be considered “best” merely because it has a high reliability coefficient. Its suitability depends on its reliability, validity, responsiveness, feasibility, interpretability, target population, and intended clinical purpose. Provide an example comparing two hypothetical neuro-rehabilitation scales. ⸻ PART 4 — GLOBAL DISABILITY Introduce the main seminar topic only after establishing the fundamentals. 1. Definition of Disability Provide the standard WHO/ICF-based definition and conceptualization of disability. Explain the WHO International Classification of Functioning, Disability and Health (ICF) framework, including: * Body functions and structures * Activity * Participation * Environmental factors * Personal factors Explain the relationship between: Impairment → Activity limitation → Participation restriction Clarify that disability is multidimensional and cannot be adequately represented by a single impairment measure. Use WHO/ICF and other authoritative references. ⸻ PART 5 — GLOBAL MEASURES OF DISABILITY Define: “Global Measure of Disability” Explain: * What is meant by a global/generic disability measure * Why global measures are useful in neuro-physiotherapy * Difference between global disability measures and disease-specific measures * Difference between impairment, activity limitation, participation restriction, and global disability * Advantages and limitations of generic/global disability measures Include the WHO Disability Assessment Schedule (WHODAS 2.0) as a major example and explain its relationship with the ICF framework. ⸻ PART 6 — DOMAINS OF GLOBAL DISABILITY Clearly explain the major functional domains assessed by global disability measures. Where applicable, include: 1. Cognition 2. Mobility 3. Self-care 4. Getting along/interpersonal relationships 5. Life activities 6. Participation 7. Communication 8. Psychological/emotional functioning 9. Social functioning 10. Role functioning Clearly indicate which domains correspond to the ICF framework. Use a reference for every major definition or conceptual statement. ⸻ PART 7 — MAXIMUM PRACTICALLY RELEVANT LIST OF GLOBAL DISABILITY SCALES Create a comprehensive list of standardized global/generic disability or functioning measures relevant to neuro-physiotherapy and neurological rehabilitation. Include, where appropriate: * WHODAS 2.0 * Functional Independence Measure (FIM) * Barthel Index * Modified Rankin Scale * Glasgow Outcome Scale / Glasgow Outcome Scale–Extended * Functional Ambulation Category * Stroke Impact Scale * SF-36 * SF-12 * EQ-5D * PROMIS Global Health * Health Utilities Index * London Handicap Scale * Craig Handicap Assessment and Reporting Technique * Functional Assessment Measure * Mayo-Portland Adaptability Inventory * Community Integration Questionnaire * Reintegration to Normal Living Index * Participation Assessment with Recombined Tools * Rivermead Mobility Index * Functional Status Examination * Other relevant generic/global disability, functioning, participation, and quality-of-life measures supported by strong evidence. Important: Do not include a scale merely because it is commonly used in neurology. Explain whether it actually measures: * Disability * Activity * Participation * Function * Quality of life * Global health Exclude purely impairment-specific measures unless they are being included for comparison. ⸻ PART 8 — MASTER COMPARISON TABLE Create a large evidence-based table with the following columns: | No. | Outcome Measure | Population/Condition | Main Purpose | Domains Covered | ICF Component | Administration Time | Reliability | Validity | Responsiveness | Feasibility | Floor/Ceiling Effects | MCID/MDC if available | Main Advantages | Main Limitations | Reference | For psychometric properties, provide actual reported values from the literature wherever available, rather than simply writing “high reliability” or “good validity.” Clearly distinguish between: * ICC * Kappa * Cronbach’s alpha * Sensitivity/specificity * AUC * SEM * MDC * MCID Do not mix values obtained from different populations without identifying the population and study. ⸻ PART 9 — SELECT THE BEST 5 MULTIDOMAIN SCALES From the complete list, identify five scales that cover more than two major disability/functioning domains and are particularly relevant to neuro-physiotherapy. Select the five based on: * Multidimensionality * Evidence quality * Reliability * Validity * Responsiveness * Clinical usefulness * Feasibility * Relevance to neurological rehabilitation Do not select scales simply because they are famous or frequently used. For each selected scale, provide a detailed section. ⸻ PART 10 — DETAILED ANALYSIS OF THE 5 SELECTED SCALES For each of the five scales explain: 1. Name and abbreviation 2. Developer/original source 3. Year of development 4. Purpose 5. Target population 6. Administration method 7. Number of items 8. Scoring system 9. Interpretation 10. Domains/components 11. ICF domains/components represented 12. Administration time 13. Reliability * Test–retest * Inter-rater * Intra-rater * Internal consistency * Relevant statistical values 14. Validity * Content validity * Construct validity * Criterion validity * Convergent/divergent validity * Relevant statistical values 15. Responsiveness * Responsiveness statistics * MDC * MCID, where established 16. Feasibility 17. Floor and ceiling effects 18. Strengths 19. Limitations 20. Clinical application in neuro-physiotherapy 21. Example of how a physiotherapist would use the scale in a patient 22. Strongest supporting references ⸻ PART 11 — PSYCHOMETRIC PROPERTIES IN DETAIL After explaining the five scales, create a dedicated comparison of their psychometric properties. Use a table: | Scale | Reliability | Validity | Responsiveness | Measurement Error | MCID/MDC | Feasibility | Overall Evidence | Then critically interpret the findings. Do not simply state that a scale is “reliable” or “valid.” Explain why, based on the reported statistics and methodological quality of the validation studies. ⸻ PART 12 — CLINICAL DECISION-MAKING End with: “How Should a Neuro-Physiotherapist Choose an Outcome Measure?” Provide a practical algorithm: Patient → Clinical question → ICF domain → Purpose of measurement → Appropriate scale → Check psychometric properties → Baseline measurement → Intervention → Reassessment → Interpretation of change Give at least 3 clinical examples, such as: 1. Stroke 2. Traumatic brain injury 3. Spinal cord injury Show which global measure(s) could be selected and why. ⸻ REFERENCE REQUIREMENTS This is extremely important. Reference quality Prioritize: 1. WHO/ICF documents 2. Original scale-development papers 3. Original validation studies 4. Systematic reviews 5. Meta-analyses 6. COSMIN literature 7. Peer-reviewed neuro-rehabilitation literature 8. Standard textbooks where appropriate Avoid using random websites, blogs, commercial websites, or unsourced educational pages. Referencing style Use Vancouver referencing style strictly. Every important factual statement, definition, psychometric value, and scale characteristic in the PPT must have an appropriate citation. Use numbered in-text citations: Example: Reliability refers to the degree to which a measurement is free from measurement error. [1] Then provide: References 1. Author AA, Author BB. Title of article. Journal. Year;volume(issue):pages. 2. World Health Organization. International Classification of Functioning, Disability and Health. Geneva: World Health Organization; 2001. Critical requirement Do not fabricate references, DOI numbers, psychometric values, MCID values, reliability coefficients, or validity statistics. When different studies report different psychometric values, clearly identify: * Study * Population * Sample size * Version/language of the scale * Statistic reported * Result Use the most authoritative and recent evidence available, while retaining original validation studies where necessary. ⸻ FINAL PPT STRUCTURE Organize the seminar approximately as follows: 1. Title 2. Learning objectives 3. What is an outcome measure? 4. Why outcome measures are important 5. Types of outcome measures 6. Measurement framework 7. Psychometric properties 8. Reliability 9. Types of reliability 10. Validity 11. Types of validity 12. Responsiveness 13. MDC vs MCID 14. Feasibility 15. Other measurement properties 16. How to identify a good outcome measure 17. Disability – definition 18. WHO/ICF framework 19. Global disability 20. Domains of global disability 21. Global disability measures in neuro-physiotherapy 22. Comprehensive list of scales 23. Master comparison table 24. Selection of five multidomain scales 25–29. Detailed analysis of the five selected scales 25. Psychometric comparison 26. Clinical application 27. Clinical decision-making algorithm 28. Key take-home messages 29. References Presentation standard The PPT should be suitable for an MPT Neuro-Physiotherapy postgraduate seminar. Use: * Clear academic language * Standard terminology * Tables wherever appropriate * Flowcharts for conceptual frameworks * Comparison tables for psychometric properties * Minimal unnecessary text * Strong evidence-based explanations * Vancouver references throughout The presentation should be critical and analytical rather than merely descriptive. Where evidence is conflicting or limited, explicitly state this rather than presenting a scale as universally superior. The final objective is that after the seminar, the audience should understand: What outcome measures are → how they are classified → what makes a measurement tool scientifically sound → how reliability and validity are assessed → what global disability means → which global disability measures are available in neuro-physiotherapy → their domains and psychometric properties → and how a neuro-physiotherapist can select the most appropriate measure for clinical practice and research.

This is a full postgraduate seminar project, so it should be developed in focused sections to keep the evidence, psychometric statistics, and Vancouver citations accurate.
Asking for Preferences

Which section should I develop in full next for the revised PPT?

Created a 22-slide seminar PowerPoint on Outcome Measures Used in Neuro-Physiotherapy: Global Measures of Disability.
It includes:
  • Basic definitions of outcome measures, disability, global disability, and domains
  • ICF framework and types of outcome measures
  • Psychometric properties
  • Reliability: types, ICC, kappa, internal consistency, SEM, MDC
  • Validity: content, construct, and criterion validity
  • Feasibility and clinical utility
  • How to decide whether a scale is more reliable or valid
  • Global disability scales: mRS, Barthel Index, FIM, DRS, GOS/GOSE, WHODAS 2.0, EDSS, MDS-UPDRS, ALSFRS-R, and SCIM
  • Scale comparison table and clinical selection example
  • Vancouver-style reference slides
  • Source citations on every content slide

Outcome Measures Neurophysiotherapy Global Disability

Presentation · PPTX

Thank you.Expanded the presentation to 38 slides with stricter reference coverage.
New content includes:
  • Detailed, standard definitions of psychometric properties
  • Reliability, measurement error, validity, responsiveness, interpretability, feasibility, floor and ceiling effects
  • Detailed explanation of ICC, weighted kappa, Cronbach alpha, SEM, MDC/SDC, and MCID/MIC
  • Three scale-catalogue tables covering a broad range of neurological outcome measures
  • For each listed scale: target population, domains covered, ICF emphasis, and psychometric considerations
  • Detailed explanation of five multi-domain measures:
    1. Functional Independence Measure (FIM)
    2. WHODAS 2.0
    3. Spinal Cord Independence Measure (SCIM)
    4. MDS-UPDRS
    5. Disability Rating Scale (DRS)
  • Expanded Vancouver reference section, now including 40 numbered references
  • Citation footer on every slide

Outcome Measures Neurophysiotherapy Global Disability DETAILED

Presentation · PPTX

Created a 10-page PDF handout containing:
  • Detailed psychometric discussion of the five selected multi-domain scales:
    • FIM
    • WHODAS 2.0
    • SCIM III
    • MDS-UPDRS
    • Disability Rating Scale
  • Reliability, measurement error, validity, responsiveness, interpretation, and feasibility points for each scale
  • A concise comparison table for the five scales
  • Slide-by-slide speaker explanations for all 38 presentation slides
  • Vancouver-style reference list

Neurophysiotherapy Global Disability Handout and Speaker Notes

PDF Document · PDF

This is a full postgraduate seminar project, so it should be developed in focused sections to keep the evidence, psychometric statistics, and Vancouver citations accurate.Your requested seminar is postgraduate-level and requires a substantial evidence base, especially for the master table and the five detailed scales. To keep every psychometric statistic and Vancouver citation accurate, it should be built in these sections:
  1. Fundamentals of outcome measurement
    • Definitions: outcome measure, assessment, measurement, evaluation, test, scale, questionnaire
    • Purpose in neuro-physiotherapy
    • Classification by ICF domain, respondent, and specificity
  2. Psychometric properties
    • Reliability, measurement error, validity, responsiveness, interpretability, feasibility
    • ICC, kappa, Cronbach alpha, SEM, MDC, MCID, ROC/AUC
    • Critical appraisal standards based on COSMIN terminology
  3. How to judge a “good” scale
    • Practical critical-appraisal checklist
    • Population, language, setting, clinical purpose, floor/ceiling effects, and meaningful-change interpretation
    • Worked comparison of two hypothetical measures
  4. Disability, ICF, and global disability
    • WHO/ICF framework
    • Impairment, activity limitation, participation restriction, and contextual factors
    • Definition and limitations of global disability measures
  5. Scale catalogue and master comparison table
    • Broad catalogue of global disability, functioning, participation, and health-related quality-of-life tools
    • Explicitly distinguish what each tool measures
    • Include available psychometric values only where supported by the cited study and population
  6. Five selected multidomain scales
    • FIM
    • WHODAS 2.0
    • SCIM III
    • MDS-UPDRS
    • Disability Rating Scale
    • Full analysis: development, domains, scoring, ICF mapping, psychometrics, feasibility, limitations, and clinical examples
  7. Clinical decision-making
    • Selection algorithm
    • Stroke, traumatic brain injury, and spinal cord injury examples
    • Key take-home messages and Vancouver references
High-level structure: the seminar should first establish measurement science, then define disability through the ICF, then critically compare scales, and finally apply scale selection to real neuro-physiotherapy decisions. This avoids the common error of presenting a list of scales without explaining whether they truly measure impairment, activity, participation, disability, quality of life, or global health.
Which section should I develop first in full for the revised PPT?
  • A. Fundamentals and classification
  • B. Psychometric properties in detail
  • C. Global disability, ICF, and domains
  • D. Scale catalogue and master comparison table
  • E. Five selected multidomain scales
  • F. Clinical decision-making and cases

Build the complete revised seminar PPT

Reading File
Reading File
Reading File
Searching the Web

COSMIN taxonomy measurement properties reliability validity responsiveness definitions official

Searching the Web

WHO ICF disability definition activity limitation participation restriction WHO official

Searching the Web

WHODAS 2.0 manual domains administration 12 item 36 item WHO

Finding Sources
Searching PubMed

Functional Independence Measure AND reliability AND validity

Searching PubMed

WHODAS 2.0 AND psychometric properties

Searching PubMed

Spinal Cord Independence Measure AND psychometric properties

Searching PubMed

MDS-UPDRS AND clinimetric AND validation

Searching PubMed

Disability Rating Scale AND traumatic brain injury AND psychometric

Browsing Directory

~/neuro-global-disability-ppt/

Searching PubMed

Functional Independence Measure AND interrater reliability

Searching PubMed

Spinal Cord Independence Measure III AND reliability validity

Searching PubMed

MDS-UPDRS AND clinimetric testing

Searching PubMed

Disability Rating Scale AND severe head trauma

Searching PubMed

WHODAS 2.0 AND reliability validity neurological

Running Command

python - <<'PY' from pathlib import Path p=Path('/tmp/workspace/neuro-global-disability-ppt/src/build_complete_revised.py') p.write_text(r'''from pptx import Presentation from pptx.util import Inches, Pt from pptx.dml.color import RGBColor from pptx.enum.text import PP_ALIGN, MSO_ANCHOR from pptx.enum.shapes import MSO_SHAPE OUT='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_COMPLETE_REVISED_SEMINAR.pptx' prs=Presentation();prs.slide_width=Inches(13.333);prs.slide_height=Inches(7.5);blank=prs.slide_layouts[6] N=RGBColor(18,45,75);T=RGBColor(0,126,135);G=RGBColor(35,126,91);O=RGBColor(245,180,60);R=RGBColor(180,61,65);I=RGBColor(31,43,54);W=RGBColor(255,255,255);P=RGBColor(244,248,250);L=RGBColor(202,218,224);M=RGBColor(91,105,118) def tx(s,t,x,y,w,h,fs=14,c=I,b=False,a=PP_ALIGN.LEFT): z=s.shapes.add_textbox(Inches(x),Inches(y),Inches(w),Inches(h));f=z.text_frame;f.clear();f.word_wrap=True;f.margin_left=f.margin_right=f.margin_top=f.margin_bottom=0;p=f.paragraphs[0];p.alignment=a;r=p.add_run();r.text=t;r.font.name='Aptos';r.font.size=Pt(fs);r.font.color.rgb=c;r.font.bold=b;return z def base(title,sub='',section=''): s=prs.slides.add_slide(blank);s.background.fill.solid();s.background.fill.fore_color.rgb=W z=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,0,prs.slide_width,Inches(.35));z.fill.solid();z.fill.fore_color.rgb=N;z.line.fill.background() tx(s,section.upper(),.55,.48,4,.2,9,T,True);tx(s,title,.55,.72,12.1,.55,25,N,True);tx(s,sub,.56,1.31,12,.25,11,M) z=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,Inches(7.13),prs.slide_width,Inches(.37));z.fill.solid();z.fill.fore_color.rgb=N;z.line.fill.background();return s def cite(s,refs):tx(s,'Sources: '+', '.join('['+str(x)+']' for x in refs),.55,7.205,12,.12,8,W) def box(s,x,y,w,h,h1,b,ac=T,fs=11): z=s.shapes.add_shape(MSO_SHAPE.ROUNDED_RECTANGLE,Inches(x),Inches(y),Inches(w),Inches(h));z.fill.solid();z.fill.fore_color.rgb=P;z.line.color.rgb=L q=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(x),Inches(y),Inches(.08),Inches(h));q.fill.solid();q.fill.fore_color.rgb=ac;q.line.fill.background();tx(s,h1,x+.2,y+.15,w-.3,.25,14,N,True);tx(s,b,x+.2,y+.49,w-.35,h-.58,fs,I) def bullets(title,sub,items,refs,sec): s=base(title,sub,sec);y=1.7 for it in items: d=s.shapes.add_shape(MSO_SHAPE.OVAL,Inches(.68),Inches(y+.08),Inches(.15),Inches(.15));d.fill.solid();d.fill.fore_color.rgb=T;d.line.fill.background();tx(s,it,.98,y,11.55,.48,13.4,I);y+=.69 cite(s,refs) def table(title,sub,heads,rows,widths,refs,sec='SCALE CATALOGUE',fs=8.2): s=base(title,sub,sec);x=.42;y=1.62 for h,w in zip(heads,widths): z=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(x),Inches(y),Inches(w),Inches(.43));z.fill.solid();z.fill.fore_color.rgb=N;z.line.fill.background();tx(s,h,x+.03,y+.1,w-.06,.2,fs,W,True,PP_ALIGN.CENTER);x+=w for ri,row in enumerate(rows): x=.42;y=2.05+ri*.49 for ci,v in enumerate(row): z=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,Inches(x),Inches(y),Inches(widths[ci]),Inches(.48));z.fill.solid();z.fill.fore_color.rgb=P if ri%2==0 else W;z.line.color.rgb=L;tx(s,v,x+.035,y+.055,widths[ci]-.07,.37,fs,I,ci==0);x+=widths[ci] cite(s,refs) # 1-2 s=prs.slides.add_slide(blank);s.background.fill.solid();s.background.fill.fore_color.rgb=N z=s.shapes.add_shape(MSO_SHAPE.RECTANGLE,0,0,Inches(.23),prs.slide_height);z.fill.solid();z.fill.fore_color.rgb=O;z.line.fill.background();tx(s,'Outcome Measures Used in\nNeuro-Physiotherapy',.8,1.2,10.4,1.4,34,W,True);tx(s,'Global Measures of Disability',.82,2.85,8,.4,22,RGBColor(184,226,230));tx(s,'Evidence-based postgraduate seminar',.82,3.52,5,.25,14,W);tx(s,'ICF • COSMIN measurement science • scale selection • critical appraisal',.82,5.9,10,.3,13,RGBColor(215,230,236));cite(s,[1,2,3]) bullets('Learning objectives','From basic measurement concepts to clinical decision-making.', ['Differentiate outcome measure, assessment, measurement, evaluation, clinical test and scale/questionnaire.','Classify neuro-physiotherapy measures by ICF domain, reporter and specificity.','Critically appraise reliability, validity, responsiveness, error, interpretability and feasibility.','Define global disability and select appropriate multidomain measures for stroke, TBI and SCI.'],[1,2,3,4],'OVERVIEW') # fundamentals s=base('What is an outcome measure?','A standardised way to quantify a defined health construct at one or more time points.','FUNDAMENTALS');box(s,.65,1.75,3.7,2.2,'Outcome measure','Instrument, test, rating scale or questionnaire that operationalises a construct using standardised administration and scoring rules. [2,4]',T);box(s,4.82,1.75,3.7,2.2,'Clinical purpose','Describes baseline status, supports goal setting, monitors change, communicates with the team, audits services and evaluates research interventions. [4,5]',O);box(s,8.98,1.75,3.7,2.2,'Neuro example','After stroke, a physiotherapist may use the Barthel Index to describe basic ADL dependence and a gait measure to quantify a mobility target. [6,7]',G);tx(s,'A measure is useful only when its construct, target population, setting and intended decision are aligned.',.9,5.2,11.4,.4,17,N,True,PP_ALIGN.CENTER);cite(s,[2,4,5,6,7]) table('Related terms: do not use them as synonyms','Each term answers a different clinical question.', ['Term','Meaning','Neuro-physiotherapy example'], [('Measurement','Assignment of numbers to attributes according to rules.','Timed 10-m walk speed in m/s.'),('Assessment','Collection and interpretation of information about a patient.','History, observation, balance tests and environmental barriers.'),('Evaluation','Judgement about meaning, progress or effectiveness using assessment data.','Conclude whether gait goal was achieved.'),('Clinical test','A standardised procedure to elicit or observe performance.','Timed Up and Go.'),('Scale/questionnaire','Set of items and response options producing a score.','WHODAS 2.0 self-report; FIM clinician rating.'),('Outcome measure','The tool selected to quantify a defined outcome.','mRS at 90 days after stroke.')],[2.2,5.2,5.45],[2,4,5],'FUNDAMENTALS',10) bullets('Why standardisation matters','Standardised administration, scoring and timing reduce avoidable variation.', ['Permits comparison across time, clinicians and services when the same version and rules are used. [2,4]','Makes treatment effects interpretable in research only if the selected measure fits the construct and has adequate measurement properties. [2,5]','Supports shared decision-making by translating goals into observable patient-relevant outcomes. [1,5]','Does not replace clinical reasoning: a total score must be interpreted with item-level findings, context and patient priorities. [1,4]'],[1,2,4,5],'FUNDAMENTALS') # classification s=base('Classification of outcome measures','Classify by construct, reporter, mode of administration and specificity.','FUNDAMENTALS');box(s,.65,1.7,3.7,1.85,'Impairment-based','Body function/structure. Example: Fugl-Meyer motor score or Modified Ashworth Scale. Advantage: treatment-targeted. Limitation: does not directly show daily function. [1,5]',T);box(s,4.82,1.7,3.7,1.85,'Activity-based','Task execution. Example: Barthel Index, Rivermead Mobility Index. Advantage: directly relevant to independence. Limitation: may omit participation. [1,6]',O);box(s,8.98,1.7,3.7,1.85,'Participation-based','Involvement in life situations. Example: CIQ or RNLI. Advantage: community relevance. Limitation: contextual influences complicate attribution. [1,8,9]',G);box(s,.65,4.05,3.7,1.85,'PROM','Patient reports health/function. Example: WHODAS, Stroke Impact Scale. Captures patient perspective; cognition, aphasia or insight can affect completion. [2,10]',T);box(s,4.82,4.05,3.7,1.85,'Performance / clinician rated','Observed test or clinician score. Example: 10MWT, FIM, mRS. Requires rater standardisation. [2,5]',O);box(s,8.98,4.05,3.7,1.85,'Generic vs specific','Generic/global: cross-condition comparison (WHODAS, EQ-5D). Disease-specific: depth in one disease (MDS-UPDRS, SCIM). [5,10,11]',G);cite(s,[1,2,5,6,8,9,10,11]) # psychometric intro s=base('Measurement framework: COSMIN','COSMIN distinguishes reliability, validity and responsiveness; feasibility is a practical selection property.','PSYCHOMETRICS');box(s,.65,1.75,3.75,2.1,'Reliability','Degree to which measurement is free from measurement error; under stable status, repeated scores should be consistent. [2,3]',T);box(s,4.78,1.75,3.75,2.1,'Validity','Degree to which evidence and theory support the intended interpretation of scores. It is not one universal number. [2,3]',O);box(s,8.9,1.75,3.75,2.1,'Responsiveness','Ability of an instrument to detect change over time in the construct to be measured. [2,3]',G);box(s,2.7,4.45,3.75,1.2,'Interpretability','Meaning assigned to score or change, including normative data, thresholds, MDC and MCID/MIC. [3,4]',R);box(s,6.85,4.45,3.75,1.2,'Feasibility','Ease of application and availability: time, cost, licensing, burden, equipment and training. [3,5]',N);cite(s,[2,3,4,5]) # reliability bullets('Reliability: standard definition and clinical meaning','Reliability asks whether repeated scores are sufficiently consistent when true status is unchanged.', ['Test-retest reliability: stability over time when no true change is expected.','Inter-rater reliability: agreement between raters assessing the same person.','Intra-rater reliability: consistency of the same rater on repeat assessment.','Internal consistency: interrelatedness of items in a unidimensional multi-item scale; not applicable to a single-item rating.','Alternate-form reliability: agreement between equivalent versions, when such forms exist.'],[2,3,4],'PSYCHOMETRICS') table('Reliability and measurement error: statistics','Use the statistic appropriate to the scale level and study design.', ['Statistic','Typical use','Interpretation / caution'], [('ICC','Continuous/approximately continuous repeated scores.','Report model, 95% CI and sample. Common guide: <0.50 poor, 0.50-0.75 moderate, 0.75-0.90 good, >0.90 excellent. Context matters. [12]'),('Kappa / weighted kappa','Nominal / ordered categorical ratings.','Weighted kappa acknowledges degree of ordinal disagreement; prevalence can affect kappa. [4]'),('Cronbach alpha','Internal consistency.','Often 0.70-0.95 considered acceptable only with unidimensionality evidence; high alpha can mean redundant items. [3]'),('SEM','Absolute measurement error.','SEM = SD√(1-ICC); smaller is more precise. [4]'),('MDC / SDC','Minimum detectable/statistically real change.','MDC95 ≈ 1.96×√2×SEM; exceeds random error, not necessarily meaningful change. [4]')],[2.3,3.2,7.35],[3,4,12],'PSYCHOMETRICS',9) bullets('Reliability: how to judge quality','Do not choose a scale from ICC or alpha alone.', ['Check that study population, severity, rater training, language, setting and retest interval resemble your clinical use. [2,3]','Inspect 95% confidence intervals and measurement error. A high ICC can coexist with a large SEM when patient scores are heterogeneous. [4,12]','For ordinal global scales use weighted agreement statistics or appropriate models, not Pearson correlation alone. [4]','Example: mRS reliability has varied across studies; structured interview and rater standardisation address observer variation. [13]'],[2,3,4,12,13],'PSYCHOMETRICS') # validity s=base('Validity: standard definition and types','Validity is evidence supporting a specific score interpretation for a stated purpose.','PSYCHOMETRICS');box(s,.65,1.7,3.7,1.85,'Content validity','Items adequately reflect the construct for target patients and intended use. Patient and expert input are central. Face validity is only apparent relevance. [2,3]',T);box(s,4.82,1.7,3.7,1.85,'Construct validity','Expected pattern of relationships: convergent, discriminant/divergent, known-groups and structural validity. Pre-specify hypotheses. [2,3]',O);box(s,8.98,1.7,3.7,1.85,'Criterion validity','Agreement with a credible gold standard: concurrent or predictive. Often no true gold standard exists for disability. [2,3]',G);box(s,.65,4.12,5.85,1.55,'Statistics','Pearson/Spearman correlations, group differences, factor/Rasch models; for diagnostic/classification purpose sensitivity, specificity and ROC/AUC may be appropriate. [2,4]',T);box(s,6.83,4.12,5.85,1.55,'Clinical example','A stroke disability scale should correlate as hypothesised with ADL dependence but not be expected to perfectly correlate with an isolated strength test. [1,6,7]',O);cite(s,[1,2,3,4,6,7]) bullets('Responsiveness, MDC and MCID/MIC','These related terms answer different questions.', ['Responsiveness is validity of a change score: can the instrument detect change in the intended construct? [2,3]','Effect size and standardised response mean describe magnitude of observed change but are influenced by sample variability and do not prove patient importance. [4]','MDC/SDC is the smallest change beyond measurement error. It answers: “Is the change likely real?” [4]','MCID/MIC is the smallest change patients perceive as important, usually estimated with an anchor. It answers: “Is the real change meaningful?” [4]','A score may exceed MDC but not MCID, or be important to a patient but still fall within measurement error. [4]'],[2,3,4],'PSYCHOMETRICS') bullets('Feasibility and other measurement properties','The best tool is scientifically sound and usable in the real clinical setting.', ['Feasibility: completion time, cost/licence, equipment, training, scoring complexity, accessibility and patient/clinician burden. WHODAS 12-item average interview time is about 5 min; 36-item about 20 min. [14]','Interpretability: ability to assign qualitative meaning to score and change. This is not itself a measurement property. [3,4]','Floor/ceiling effects: clustering at extremes can reduce discrimination and responsiveness. [3,4]','Cross-cultural validity/measurement invariance: same construct is measured equivalently across language/cultural groups. [2,3]','Structural validity: score structure reflects the dimensionality of the intended construct. [2,3]'],[2,3,4,14],'PSYCHOMETRICS') # good scale s=base('How do we know whether an outcome measure is “good”?','Use a critical appraisal checklist, not a popularity contest.','CRITICAL APPRAISAL');items=[('1. Construct','Does it measure the ICF domain and outcome you actually need?'),('2. Population','Validated in comparable diagnosis, severity, language and setting?'),('3. Reliability/error','Appropriate ICC/kappa/SEM/MDC with acceptable precision?'),('4. Validity','Content, structural and construct/criterion evidence fit interpretation?'),('5. Responsiveness','Evidence for the intended time frame and intervention?'),('6. Meaning','MDC/MCID, floor/ceiling effects and reporting rules known?'),('7. Feasibility','Time, training, burden, cost, licence and access acceptable?')] for i,(h,b) in enumerate(items): x=.65+(i%2)*6.15;y=1.65+(i//2)*1.28;box(s,x,y,5.8,1.03,h,b,[T,O,G,R,N,T,G][i],10.5) cite(s,[2,3,4,5]) s=base('Critical appraisal example','Two hypothetical stroke rehabilitation scales.','CRITICAL APPRAISAL');box(s,.7,1.75,5.75,3.85,'Scale A','ICC 0.95 in a mixed outpatient sample, but only mobility items; no MDC/MCID; 30 min administration. It may be excellent for stable mobility measurement but not a complete disability measure.',T,12);box(s,6.87,1.75,5.75,3.85,'Scale B','ICC 0.82 with small SEM in post-stroke inpatients; valid ADL content; 10 min; has a reported MDC in a comparable population. It may be more useful for a ward-based ADL monitoring decision.',O,12);tx(s,'Conclusion: “best” depends on construct, precision, population and purpose. Reliability coefficient alone is insufficient. [2-5]',.9,5.95,11.5,.35,15,N,True,PP_ALIGN.CENTER);cite(s,[2,3,4,5]) # ICF global s=base('Disability: WHO/ICF definition','Disability is multidimensional and interactional, not a synonym for impairment.','GLOBAL DISABILITY');box(s,.65,1.75,3.75,2.1,'WHO/ICF','Disability is an umbrella term for impairments, activity limitations and participation restrictions, arising from interaction with personal and environmental factors. [1]',T);box(s,4.78,1.75,3.75,2.1,'ICF components','Body functions/structures; activities; participation; environmental factors; personal factors. [1]',O);box(s,8.9,1.75,3.75,2.1,'Example','Stroke weakness (impairment) may limit stair climbing (activity), restrict community access/work (participation), and be modified by home stairs or a mobility aid (environment). [1]',G);tx(s,'Impairment → activity limitation → participation restriction is a useful clinical pathway, but ICF relationships are bidirectional and context dependent.',.85,5.15,11.65,.45,16,N,True,PP_ALIGN.CENTER);cite(s,[1]) s=base('What is a global measure of disability?','A broad summary of functional consequence, dependence or disability burden.','GLOBAL DISABILITY');box(s,.65,1.7,3.75,2.05,'What it does','Integrates several activities/domains or uses an overall ordinal judgement to communicate broad status. Example: WHODAS, FIM, mRS, DRS. [6,10,14,15]',T);box(s,4.78,1.7,3.75,2.05,'Why useful','Facilitates baseline description, service outcomes, cross-disciplinary communication and broad endpoints in research. [5,10]',O);box(s,8.9,1.7,3.75,2.05,'Limitations','May hide the specific task causing disability; ordinal totals may be non-linear; generic measures can be less sensitive to disease-specific change. [1,4,5]',R);box(s,2.7,4.45,7.95,1.15,'Global versus disease-specific','Global/generic measures support breadth and cross-condition comparison. Disease-specific measures target condition-relevant features, often with greater clinical detail but less cross-condition comparability. [5,10,11]',G);cite(s,[1,4,5,6,10,11,14,15]) table('Domains of global disability and ICF mapping','No single instrument covers every domain equally.', ['Domain','ICF emphasis','Examples of measures'], [('Cognition / communication','Activity; body functions may contribute','WHODAS cognition; FIM communication/social cognition; MDS-UPDRS Part I.'),('Mobility / transfers','Activity','WHODAS mobility; FIM locomotion; SCIM mobility; BI.'),('Self-care','Activity','WHODAS self-care; FIM self-care; BI; SCIM self-care.'),('Interpersonal / social function','Participation / activity','WHODAS getting along; FIM social cognition; CIQ.'),('Life activities / roles','Participation','WHODAS life activities; RNLI; PART.'),('Participation / community','Participation','WHODAS participation; CHART; CIQ; Stroke Impact Scale.'),('Psychological / emotional impact','Body functions / participation','SF-36 mental health; PDQ-39 emotional well-being; MDS-UPDRS non-motor experiences.')],[2.3,3.2,7.35],[1,10,14,16,17],'GLOBAL DISABILITY',9) # catalogue rows1=[('WHODAS 2.0','Adults, cross-condition','Activity + participation','6 domains; 12/36 items','12-item ~5 min; 36-item ~20 min [14]','[10,14]'),('FIM','Rehabilitation','Dependence / burden of care','13 motor + 5 cognitive','Clinician rated; training required','[15,16]'),('Barthel Index','Stroke/general rehab','Basic ADL activity','10 ADL/mobility items','Brief; common 0-100 score','[6,7]'),('mRS','Stroke','Global disability','Single 0-6 ordinal rating','Very brief; structured interview preferred','[13,18]'),('GOS/GOSE','TBI','Global recovery','Survival, independence, role','Structured interview improves consistency','[19]'),('FAM','Brain injury','Function / cognition / psychosocial','FIM plus additional items','Use with FIM framework','[20]'),('DRS','TBI','Global disability trajectory','8 ratings, coma to community','Brief; broad ordinal summary','[21,22]'),('Stroke Impact Scale','Stroke','Patient-reported impact','Multiple function/participation domains','PROM; not generic','[23]')] table('Global and broad measures I','Classification is explicit: scales are not treated as equivalent.',['Measure','Population','Main construct','Domains / format','Feasibility','Ref'],rows1,[1.35,1.55,1.9,3.3,3.75,.8],[6,7,10,13,14,15,16,18,19,20,21,22,23],'SCALE CATALOGUE',7.6) rows2=[('SF-36 / SF-12','Cross-condition','Health-related QoL','Physical + mental health domains','PROM; generic health profile','[24]'),('EQ-5D','Cross-condition','Health status / utility','Mobility, self-care, usual activities, pain, anxiety/depression','Brief PROM; utilities depend on value set','[25]'),('PROMIS Global Health','Cross-condition','Global physical/mental health','Global health profile','PROM; item-bank framework','[26]'),('Health Utilities Index','Cross-condition','Health utility','Multi-attribute health status','PROM/proxy options','[27]'),('London Handicap Scale','Disability/handicap','Participation disadvantage','Six survival/role domains','Older participation-oriented measure','[28]'),('CHART','SCI','Participation/handicap','Physical independence, mobility, occupation, social integration, economic self-sufficiency','SCI/community focus','[29]'),('CIQ','TBI','Community integration','Home, social, productive activity','Participation focused','[8]'),('RNLI','Neuro/general','Reintegration','Mobility, self-care, role/social participation','Participation-focused PROM','[9]')] table('Global, health and participation measures II','These measure disability-related constructs, global health or participation, not necessarily basic ADL.',['Measure','Population','Main construct','Domains / format','Feasibility','Ref'],rows2,[1.35,1.55,1.9,3.3,3.75,.8],[8,9,24,25,26,27,28,29],'SCALE CATALOGUE',7.6) rows3=[('SCIM III','SCI','Independence','Self-care; respiration/sphincter; mobility','SCI-specific clinician rating','[11,30]'),('MDS-UPDRS','Parkinson disease','Disease impact/severity','4 parts: non-motor ADL, motor ADL, motor exam, complications','Patient + clinician components','[31,32]'),('EDSS','Multiple sclerosis','MS disability','Functional systems + ambulation','Ambulation-weighted; ordinal','[33]'),('MSIS-29','Multiple sclerosis','Patient-reported impact','Physical and psychological impact','PROM; disease-specific','[34]'),('ALSFRS-R','ALS','Functional disability','Bulbar, fine/gross motor, respiratory','Disease-specific rating','[35]'),('FAC','Neurorehab','Walking assistance','6 ambulation categories','Walking only, not global disability','[36]'),('Rivermead Mobility Index','Neurorehab','Mobility activity','Bed mobility to running','Mobility only','[37]'),('Mayo-Portland Adaptability Inventory','TBI','Abilities/adjustment/participation','Multidomain brain injury participation','TBI community rehabilitation','[38]')] table('Disease-specific and comparator measures III','Some are included to show what they do, not to label all as global disability scales.',['Measure','Population','Main construct','Domains / format','Feasibility','Ref'],rows3,[1.35,1.55,1.9,3.3,3.75,.8],[11,30,31,32,33,34,35,36,37,38],'SCALE CATALOGUE',7.6) # master table values cautious master=[('WHODAS 2.0','Cross-condition','Activity/participation','6 ICF A/P domains','12: ~5; 36: ~20 min','Systematic reviews: varies by version/population; examine exact form','Stroke/SCI validations published','Population-specific; do not assume universal MDC/MCID','Broad, ICF linked','Respondent/cognitive burden','[10,14,39-41]'),('FIM','Rehabilitation','Dependence','Motor + cognitive','Training dependent','Inter-rater study reported [16]','Content/activity linkage; compare totals cautiously','No universal MDC/MCID','Burden of care profile','Licence/training; limited participation','[15,16]'),('Barthel','Stroke/rehab','Basic ADL','10 ADL items','Brief','Stroke meta-analysis weighted κ=0.93 (95% CI 0.90-0.96) [7]','Established ADL content; relation to mRS/FIM studied','Population-specific','Simple ADL score','Ceiling/floor; little cognition','[6,7,42]'),('mRS','Stroke','Global disability','1 global ordinal rating','Very brief','Systematic review: weighted κ 0.87-0.90 across methods; observer variability remains [13]','Global stroke outcome construct','No universal MCID','Brief endpoint','Sparse detail; ordinal','[13,18]'),('SCIM III','SCI','Independence','3 SCI-specific domains','Clinician rated','Multicentre reliability/validity study [30]','SCI-specific content validity','Check version-specific evidence','SCI relevance','Not cross-condition','[11,30]'),('MDS-UPDRS','PD','Disease impact','4 parts, motor/non-motor','Moderate; trained examiner','Clinimetric testing and validation published [31,32]','Construct/structural evidence published','Context-dependent; no universal MCID','Detailed PD profile','Not generic disability','[31,32]'),('DRS','TBI','Global disability','8 coma-to-community ratings','Brief','Psychometric/utility review available [22]','Broad TBI recovery content','No universal MCID','Across recovery continuum','Not detailed domain profile','[21,22]')] table('Master comparison table: selected key measures','Reported values are shown only when verified in the cited source; “no universal” means do not import a threshold from another population.', ['Measure','Population','Purpose','Domains/ICF','Time','Reliability','Validity','Resp./MDC/MCID','Advantage','Limitation','Ref'],master,[1.05,1.0,1.15,1.55,1.05,1.75,1.5,1.55,1.2,1.3,.75],[6,7,10,11,13,14,15,16,18,21,22,30,31,32,39,40,41,42],'MASTER TABLE',6.3) # five selection s=base('Selection of five multidomain scales','Selection criterion: >2 domains, relevant neuro-physiotherapy use, evidence base and clinical feasibility.','SELECTED SCALES');table_data=[('FIM','6 domains, motor + cognition','Rehabilitation dependence / assistance planning'),('WHODAS 2.0','6 activity/participation domains','Cross-condition disability and participation'),('SCIM III','Self-care, respiration/sphincter, mobility','SCI-specific independence'),('MDS-UPDRS','4 parts, motor + non-motor','Parkinson disease multidomain monitoring'),('DRS','Arousal, cognition, dependence, psychosocial role','TBI recovery from coma to community')];x=.65;y=1.72 for i,(a,b,c) in enumerate(table_data):box(s,.7,y,11.9,.75,a,b+' | '+c,[T,O,G,R,N][i],10);y+=.84 cite(s,[10,11,15,21,30,31]) # details helper def detail(name,subtitle,about,domains,psych,clinical,refs): s=base(name,subtitle,'SELECTED SCALES');box(s,.65,1.7,3.75,3.95,'Description & scoring',about,T,11);box(s,4.78,1.7,3.75,3.95,'Domains / ICF',domains,O,11);box(s,8.9,1.7,3.75,3.95,'Psychometrics & use',psych+'\n\nClinical example: '+clinical,G,10.5);cite(s,refs) detail('Functional Independence Measure (FIM)','Developer: Keith et al., 1987. [15]','18 clinician-rated items: 13 motor + 5 cognitive. Each item 1 (total assistance) to 7 (complete independence); total 18-126. Record motor and cognitive components, not only total. [15]','Self-care; sphincter control; transfers; locomotion; communication; social cognition. Primarily ICF activity; cognitive/social components also inform functioning. [15]','Reliability: inter-rater reliability study published; standard scoring/training is required. [16]\nValidity: content targets dependence/burden of care; it is not a direct participation or QoL measure. [15,42]\nResponsiveness/MDC/MCID: use population-specific evidence; no single universal threshold.','Post-stroke inpatient: identify transfer, locomotion and self-care assistance needs at admission and discharge; add a gait/balance measure for physiotherapy-specific change.',[15,16,42]) detail('WHODAS 2.0','WHO ICF-based generic functioning assessment. [10,14]','36-item version gives overall and 6 domain scores; interviewer, self and proxy forms; average interview ~20 min. 12-item version gives overall score; average ~5 min. [14]','Cognition; mobility; self-care; getting along; life activities; participation. Directly aligned with ICF activity and participation. [10,14]','Reliability/validity: systematic reviews and neurological validation studies exist, but values vary by version, language, respondent and population. [39-41]\nResponsiveness/MDC/MCID: do not assume a value across forms or conditions.\nFeasibility: record mode of completion, especially with aphasia/cognitive impairment.','SCI outpatient: use 36-item WHODAS when the goal includes community participation and life activities, not only independence in basic ADLs.',[10,14,39,40,41]) detail('Spinal Cord Independence Measure III (SCIM III)','Developer: Catz et al.; SCI-specific scale. [11,30]','Independence score designed for persons with SCI. Items address practical independence; use the official current manual/version for scoring. [11,30]','Self-care; respiration and sphincter management; indoor/outdoor mobility including transfers. Predominantly ICF activity; content is SCI-specific. [11,30]','Reliability/validity: multicentre international study reported reliability and validity. [30]\nResponsiveness/MDC/MCID: interpret in the SCI population and avoid transferring generic thresholds.\nStrength: relevant bladder/bowel, respiratory and wheelchair-related tasks.','Cervical SCI: set goals around dressing, bowel management and wheelchair transfer; inspect domain/item change rather than only total.',[11,30]) detail('Movement Disorder Society-UPDRS (MDS-UPDRS)','Developer: Goetz et al., 2008; Parkinson disease-specific. [31]','Four parts: I non-motor experiences of daily living, II motor experiences of daily living, III motor examination, IV motor complications. Includes patient and examiner components. [31]','Motor and non-motor daily living, examination and complications. Maps to body functions plus activity/participation consequences; not a generic disability scale. [31]','Reliability/validity: original clinimetric testing and independent validation reported. [31,32]\nFeasibility: standardise medication timing, ON/OFF state and examiner technique.\nInterpret parts separately; total can hide opposite changes in different parts.','Parkinson disease: document Part II and III at comparable medication state while pairing with a participation goal such as community walking.',[31,32]) detail('Disability Rating Scale (DRS)','Developer: Rappaport et al., 1982; severe TBI recovery scale. [21]','Eight ratings spanning arousal/awareness, cognitive ability for self-care, dependence and psychosocial adaptability/employability. Designed from coma to community. [21]','Arousal/awareness, cognition for self-care, dependence and role adaptation. Crosses impairment, activity and participation-related consequences. [21,22]','Reliability/validity: clinical utility and psychometric review available. [22]\nInterpretation: broad ordinal score, so complement with mobility, cognition and participation measures for treatment planning.\nNo universal MCID should be assumed.','Severe TBI: track broad recovery stage using DRS while separately measuring transfer safety, gait and community integration.',[21,22]) # five scale comparison table('Psychometric comparison of the five selected scales','Evidence should be interpreted at scale-version and population level.', ['Scale','Reliability','Validity','Responsiveness / error','Feasibility','Critical interpretation'], [('FIM','Inter-rater study; require training. [16]','Content for independence/burden of care. [15]','No universal MDC/MCID.','Moderate; licensing/training context.','Good for inpatient dependence; limited participation.'),('WHODAS','Evidence varies by form/language/population. [39-41]','ICF-linked 6-domain content. [10,14]','No cross-form universal threshold.','12-item high; 36-item moderate.','Broad A/P, but respondent burden and cognitive access matter.'),('SCIM III','Multicentre reliability/validity study. [30]','SCI-specific content. [11]','Use SCI-specific evidence.','Moderate clinician burden.','Strong clinical fit for SCI, not generic comparison.'),('MDS-UPDRS','Clinimetric testing/validation. [31,32]','Multidomain PD construct.','Medication state affects serial comparison.','Moderate.','Report parts; not generic disability.'),('DRS','Review supports utility; ordinal broad score. [22]','TBI recovery continuum. [21]','No universal MCID.','High feasibility.','Useful trajectory; low domain specificity.')],[1.25,2.25,2.25,2.1,1.8,3.0],[10,11,14,15,16,21,22,30,31,32,39,40,41],'SELECTED SCALES',7.5) # clinical algorithm s=base('Clinical decision-making algorithm','Outcome measure selection begins with the decision, not the scale name.','APPLICATION');steps=['Patient and context','Clinical question','ICF construct/domain','Purpose: baseline, goal, monitoring, endpoint','Candidate scale(s)','Check population-specific psychometrics + feasibility','Baseline with standard rules','Intervention and reassessment','Interpret change: error + importance + item profile'];x=.62;y=1.62 for i,a in enumerate(steps): z=s.shapes.add_shape(MSO_SHAPE.ROUNDED_RECTANGLE,Inches(x),Inches(y),Inches(2.35),Inches(.63));z.fill.solid();z.fill.fore_color.rgb=P;z.line.color.rgb=L;tx(s,str(i+1)+'. '+a,x+.1,y+.18,2.15,.2,9.5,N,True,PP_ALIGN.CENTER);x+=2.53 if x>11.5:x=.62;y+=1.05 cite(s,[1,2,3,4,5]) s=base('Clinical applications: stroke, TBI and SCI','Use a broad measure plus a target-specific measure when necessary.','APPLICATION');box(s,.65,1.7,3.75,3.9,'Stroke','Question: broad disability endpoint + ADL assistance?\n\nmRS: brief overall stroke disability endpoint.\nBarthel or FIM: basic ADL/dependence profile.\nAdd gait/balance measure when mobility is the treatment target. [6,7,13,15]',T,11);box(s,4.78,1.7,3.75,3.9,'Traumatic brain injury','Question: recovery from severe injury and community reintegration?\n\nDRS: broad coma-to-community trajectory.\nGOSE: global outcome category.\nAdd CIQ/Mayo-Portland and specific mobility/cognition tools for participation and treatment targets. [8,19,21,22,38]',O,11);box(s,8.9,1.7,3.75,3.9,'Spinal cord injury','Question: SCI-specific independence?\n\nSCIM III: self-care, sphincter/respiration and mobility.\nWHODAS: broader activity/participation perspective.\nAdd WISCI/FAC only when walking is the specific target. [10,11,30,36]',G,11);cite(s,[6,7,8,10,11,13,15,19,21,22,30,36,38]) bullets('Key take-home messages','', ['Outcome measures quantify a defined construct. Assessment and clinical reasoning are broader processes.','A “good” scale has adequate evidence for its intended score interpretation in the right population and setting.','Reliability, validity, responsiveness, error, feasibility and interpretability must all be considered.','Global disability is multidimensional. Pair global scores with domain-specific measures for physiotherapy treatment planning.','Do not fabricate or transfer MDC/MCID, reliability or validity values across languages, versions or clinical populations.'],[1,2,3,4,5],'SUMMARY') # refs 1-42 refs=['World Health Organization. International classification of functioning, disability and health: ICF. Geneva: WHO; 2001.','Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties. J Clin Epidemiol. 2010;63(7):737-45.','Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34-42.','de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.','Playford ED. Outcome measurement in neurological disease. Curr Opin Neurol. 2008;21(4):461-6.','Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-5.','Duffy L, Gajree S, Langhorne P, Stott DJ, Quinn TJ. Reliability of the Barthel Index for assessment of stroke survivors: systematic review and meta-analysis. Stroke. 2013;44(2):462-8.','Willer B, Ottenbacher KJ, Coad ML. The Community Integration Questionnaire. A comparative examination. Am J Phys Med Rehabil. 1994;73(2):103-11.','Wood-Dauphinee SL, Opzoomer MA, Williams JI, Marchand B, Spitzer WO. Assessment of global function: the Reintegration to Normal Living Index. Arch Phys Med Rehabil. 1988;69(8):583-90.','Üstün TB, Kostanjsek N, Chatterji S, Rehm J, editors. Measuring health and disability: manual for WHO Disability Assessment Schedule WHODAS 2.0. Geneva: WHO; 2010.','Catz A, Itzkovich M, Agranov E, Ring H, Tamir A. SCIM-spinal cord independence measure: a new disability scale for patients with spinal cord lesions. Spinal Cord. 1997;35(12):850-6.','Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155-63.','Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393-5.','World Health Organization. WHO Disability Assessment Schedule 2.0. Geneva: WHO; 2026.','Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.','Hamilton BB, Laughlin JA, Fiedler RC, Granger CV. Interrater reliability of the 7-level Functional Independence Measure. Scand J Rehabil Med. 1994;26(3):115-9.','World Health Organization. WHO Disability Assessment Schedule (WHODAS 2.0). Geneva: WHO; 2026.','van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604-7.','Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale. J Neurotrauma. 1998;15(8):573-85.','Hall KM, Mann N, High WM, Wright J, Kreutzer JS, Wood D. Functional measures after traumatic brain injury: ceiling effects of FIM, FIM+FAM, DRS, and CIQ. J Head Trauma Rehabil. 1996;11(5):27-39.','Rappaport M, Hall KM, Hopkins K, Belleza T, Cope DN. Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil. 1982;63(3):118-23.','Williams MW, Smith EL. Clinical utility and psychometric properties of the Disability Rating Scale with individuals with traumatic brain injury. Rehabil Psychol. 2017;62(3):339-45.','Duncan PW, Bode RK, Min Lai S, Perera S. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Arch Phys Med Rehabil. 2003;84(7):950-63.','Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). Med Care. 1992;30(6):473-83.','EuroQol Group. EuroQol - a new facility for measurement of health-related quality of life. Health Policy. 1990;16(3):199-208.','Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from PROMIS global items. Qual Life Res. 2009;18(7):873-80.','Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics. 1995;7(6):490-502.','Harwood RH, Rogers A, Dickinson E, Ebrahim S. Measuring handicap: the London Handicap Scale. J Neurol Neurosurg Psychiatry. 1994;57(7):825-30.','Whiteneck GG, Charlifue SW, Gerhart KA, Overholser JD, Richardson GN. Quantifying handicap: a new measure of long-term rehabilitation outcomes. Arch Phys Med Rehabil. 1992;73(6):519-26.','Itzkovich M, Gelernter I, Biering-Sørensen F, Weeks C, Laramee MT, Craven BC, et al. The Spinal Cord Independence Measure version III: reliability and validity in a multi-center international study. Disabil Rehabil. 2007;29(24):1926-33.','Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. MDS-UPDRS: scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129-70.','Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, et al. Expanded and independent validation of the MDS-UPDRS. J Neurol. 2013;260(1):228-36.','Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology. 1983;33(11):1444-52.','Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29). Brain. 2001;124(Pt 5):962-73.','Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R. J Neurol Sci. 1999;169(1-2):13-21.','Holden MK, Gill KM, Magliozzi MR. Gait assessment for neurologically impaired patients: standards for outcome assessment. Phys Ther. 1986;66(10):1530-9.','Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index. Int Disabil Stud. 1991;13(2):50-4.','Malec JF. The Mayo-Portland Adaptability Inventory. J Head Trauma Rehabil. 2005;20(4):298-300.','Federici S, Bracalenti M, Meloni F. WHODAS 2.0: an international systematic review. Disabil Rehabil. 2017;39(23):2347-80.','Saltychev M, Katajapuu N, Bärlund E, et al. Psychometric properties of 12-item self-administered WHODAS 2.0: systematic review. Disabil Rehabil. 2021;43(25):3532-40.','Küçükdeveci AA, Kutlay S, Yıldızlar D, et al. Reliability and validity of WHODAS-II in stroke. Disabil Rehabil. 2013;35(3):214-20.','Kwon S, Hartzema AG, Duncan PW, Min-Lai S. Disability measures in stroke: relationship among Barthel Index, FIM, and mRS. Stroke. 2004;35(4):918-23.'] for start in range(0,len(refs),11): s=base('References '+str(start+1)+'-'+str(min(start+11,len(refs))),'Vancouver style','REFERENCES');y=1.55 for j,r in enumerate(refs[start:start+11],start+1):tx(s,str(j)+'. '+r,.65,y,12,.32,8.8,I);y+=.47 cite(s,list(range(start+1,min(start+11,len(refs))+1))) prs.save(OUT);print(OUT,len(prs.slides)) ''') PY python "/tmp/workspace/neuro-global-disability-ppt/src/build_complete_revised.py"

Running Command

python - <<'PY' from pptx import Presentation import os, re p='/tmp/workspace/neuro-global-disability-ppt/output/Outcome_Measures_Neurophysiotherapy_COMPLETE_REVISED_SEMINAR.pptx' prs=Presentation(p) print('slides',len(prs.slides),'bytes',os.path.getsize(p)) missing=[] for i,sl in enumerate(prs.slides,1): alltext='\n'.join(sh.text for sh in sl.shapes if getattr(sh,'has_text_frame',False)) if 'Sources:' not in alltext: missing.append(i) title=next((sh.text.replace('\n',' | ') for sh in sl.shapes if getattr(sh,'has_text_frame',False) and sh.text.strip() and not sh.text.startswith('Sources:')), '') print(f'{i:02d}: {title[:90]}') print('slides missing citation footer:',missing) # check refs used do not exceed final ref count nums=[] for sl in prs.slides: for sh in sl.shapes: if getattr(sh,'has_text_frame',False): nums += [int(x) for x in re.findall(r'\[(\d+)\]',sh.text)] print('citation range',min(nums),max(nums),'references',42) PY

Built the complete revised 36-slide postgraduate seminar PPT with:
  • Fundamentals of outcome measurement and terminology
  • Classification of neuro-physiotherapy outcome measures
  • Detailed psychometric properties: reliability, validity, responsiveness, MDC, MCID, measurement error, feasibility, interpretability, and floor/ceiling effects
  • Critical appraisal checklist for choosing a good scale
  • WHO/ICF framework and global disability concepts
  • Global disability domains and ICF mapping
  • Three scale-catalogue tables that distinguish disability, activity, participation, global health, quality of life, and disease-specific measures
  • Evidence-based master comparison table with verified reported psychometric information where available
  • Detailed analyses of five multidomain scales:
    • FIM
    • WHODAS 2.0
    • SCIM III
    • MDS-UPDRS
    • Disability Rating Scale
  • Psychometric comparison of the five scales
  • Clinical decision-making algorithm
  • Stroke, traumatic brain injury, and spinal cord injury examples
  • Vancouver-style references and numbered citation footer on every slide

Outcome Measures Neurophysiotherapy COMPLETE REVISED SEMINAR

Presentation · PPTX

This is a shared conversation. Sign in to Orris to start your own chat.